hg_102997.1

Basic information about the TSS

---

TSS ID: hg_102997.1 Species: human Chr: chr9		Start: 133376038 End: 133376082 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000371989.8 ENST00000371991.3 AK299656 AF078866 AF078867 AK303309 AK295435 AK300004 AK316480 Distance: 0 GeneID: 6836 HGNC/MGI_ID: HGNC:11476 UniProt_ID: B7Z605 B7Z8F3 O15260 Q5T8U5

Gene_name: surfeit 4 Gene_symbol: SURF4 Gene_synonyms: ERV29 FLJ22993 MGC102753 Gene_source: HGNC:11476

TATA-Box annotation

---

Distance to TSS:	0
Nearest PromoterID:	NM_033161
Entrez ID:	6836
Nearest Unigene:	Hs.512465
Nearest Refseq:	NM_033161
Nearest Ensembl:	ENSG00000148248
Gene Name:	surfeit 4
Gene Alias:	ERV29
Gene Description:	surfeit 4
Gene Type:	protein-coding
CpG%:	0.165
GC%:	0.791045
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	-73(GCCCCTTTAAGG,-,0.00),-72(CCCCTTTAAGGC,-,0.00),-71(CCCTTTAAGGCT,+,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SURF4 p2@SURF4 p3@SURF4 p4@SURF4 p7@SURF4 p8@SURF4
Sample		p1@SURF4	p2@SURF4	p3@SURF4	p4@SURF4	p7@SURF4	p8@SURF4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	63.51	25.32	5.84	1.75	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	64.54	25.69	8.30	3.03	1.01	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	62.89	24.31	4.63	2.31	0.00	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	56.34	24.53	5.41	2.29	0.00	0.42
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	56.47	24.52	6.07	2.70	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	58.53	21.13	5.23	2.13	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	85.85	32.68	9.15	2.40	0.44	0.00
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	56.68	30.52	7.51	0.97	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	72.02	36.76	9.40	3.63	0.43	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	48.11	17.39	7.54	2.90	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	40.02	15.36	8.08	3.64	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	46.35	14.23	4.88	2.44	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	42.72	13.06	4.84	0.81	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	35.18	9.32	4.21	1.80	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	43.25	14.71	3.73	1.32	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	34.96	10.31	3.27	2.26	0.00	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	33.42	10.27	3.06	2.18	0.00	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	37.12	10.12	2.11	2.11	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	32.52	6.93	5.86	1.07	0.00	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	41.07	10.68	3.76	2.11	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	44.64	13.63	4.14	1.34	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	38.50	11.57	2.93	2.07	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	40.46	12.15	3.36	1.55	0.26	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	34.22	12.86	3.64	1.94	0.49	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	42.57	13.67	3.10	1.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	37.66	11.71	3.48	1.27	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	36.81	12.64	3.85	3.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	48.09	13.67	4.48	1.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	46.36	15.34	3.23	2.10	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	43.25	13.57	3.98	1.27	0.18	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	42.92	12.77	3.98	1.47	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	41.23	10.75	4.49	1.76	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	47.27	9.92	3.80	2.53	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	33.32	9.07	2.97	1.81	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	40.76	15.52	3.93	0.75	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	49.44	13.61	4.79	2.68	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	45.17	11.65	4.70	1.43	0.61	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	46.95	13.50	5.24	2.62	0.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	47.54	13.24	6.48	1.62	0.27	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	45.37	15.36	3.84	1.44	0.48	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	42.82	16.23	4.23	0.71	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	43.48	8.20	3.07	1.61	0.00	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	50.83	17.93	5.27	4.22	0.00	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	54.55	18.36	6.64	2.10	0.00	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	50.59	14.25	7.03	1.81	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	51.18	17.91	5.35	1.40	0.23	0.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	53.50	14.87	5.76	1.44	0.24	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	51.86	15.20	3.87	1.19	0.30	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	73.49	18.43	6.70	4.55	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	50.75	17.59	4.65	3.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	55.34	12.30	6.15	4.10	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	72.94	18.23	9.12	7.34	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	0.00	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	78.42	22.36	7.81	5.32	0.71	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	76.55	20.88	6.96	6.63	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	33.56	2.52	1.68	0.84	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	45.01	11.94	3.21	4.13	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	88.81	17.18	5.51	8.75	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	75.80	26.01	8.67	5.46	0.00	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	53.75	11.94	4.09	4.09	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	96.59	26.09	10.58	6.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	96.46	19.07	8.97	5.61	0.00	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	27.86	3.98	1.59	0.80	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	50.29	14.61	4.76	4.08	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	100.08	33.47	8.12	7.80	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	85.55	25.91	7.45	4.61	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	55.28	7.90	0.00	7.90	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	86.78	30.71	7.31	3.41	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	87.27	31.74	8.93	4.46	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	92.88	25.80	3.28	3.28	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	75.18	16.89	6.95	2.65	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	94.04	29.70	7.11	3.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	108.23	32.10	7.95	4.89	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	121.96	38.01	6.97	8.24	0.95	1.11
Adipocyte - breast, donor2	11327-117E4	112.94	58.88	5.13	8.98	0.96	0.48
Adipocyte - omental, donor1	11473-119C6	128.37	39.57	8.27	8.52	1.02	0.38
Adipocyte - omental, donor2	11474-119C7	112.87	46.34	3.74	8.97	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	99.14	34.50	8.71	6.03	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	160.77	43.38	7.66	7.66	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	73.67	34.08	3.30	4.40	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	114.26	34.78	10.84	10.39	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	106.00	27.63	7.30	5.39	1.04	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	151.37	56.91	9.97	9.58	0.00	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	128.17	57.65	5.15	8.49	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	128.24	49.34	6.41	10.31	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	89.35	25.86	8.23	3.53	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	149.12	87.27	4.34	10.54	0.24	1.21
Adipocyte differentiation, day08, donor2	13023-139D8	81.66	30.34	2.26	4.84	0.00	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	97.04	42.66	5.87	6.40	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	89.03	37.28	4.45	5.01	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	159.70	103.56	3.33	10.40	0.83	0.42
Adipocyte differentiation, day12, donor2	13024-139D9	86.15	36.92	3.01	6.78	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	101.77	62.18	4.91	7.85	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	84.95	57.55	3.35	7.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	186.30	74.26	10.17	14.81	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	214.79	55.58	8.96	11.47	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	113.81	21.56	5.99	8.39	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	116.94	39.04	10.61	6.12	0.00	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	100.41	25.10	20.08	3.35	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	116.28	38.42	9.25	4.93	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	105.39	23.46	9.27	4.23	0.11	0.23
Anulus Pulposus Cell, donor2	11463-119B5	96.00	33.31	9.31	4.41	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	78.63	19.32	6.74	8.54	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	89.00	29.52	8.25	6.51	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	74.91	32.10	17.12	10.70	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	78.02	26.60	5.38	6.58	0.30	0.30
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	73.35	21.50	3.79	5.06	0.00	1.26
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	83.17	25.74	3.96	7.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	72.12	17.54	5.20	10.07	0.32	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	100.00	27.18	5.83	11.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	92.65	26.72	5.94	5.34	0.59	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	88.13	27.87	6.03	6.40	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	91.43	29.03	7.98	7.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	85.26	35.11	11.28	6.27	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	111.36	39.87	8.40	8.40	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	72.33	32.76	8.19	9.55	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	99.97	33.93	8.29	7.09	0.15	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	99.66	27.33	6.43	9.64	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	106.75	33.63	6.99	10.01	0.19	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	102.10	34.48	8.02	10.16	0.53	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	79.01	19.51	3.90	4.88	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	96.03	29.03	7.63	7.80	0.33	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	92.46	24.01	9.61	8.41	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	60.18	28.32	0.00	10.62	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	96.57	30.88	7.55	10.46	0.34	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	88.09	25.17	8.39	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	93.69	26.70	6.80	9.22	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	103.59	34.15	7.97	6.07	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	82.37	32.71	6.06	1.21	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	97.48	23.37	6.27	3.42	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	96.41	32.49	8.98	10.47	0.43	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	98.07	29.68	7.48	5.42	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	91.50	16.42	5.63	8.45	0.00	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	92.93	32.48	5.79	7.72	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	105.59	25.68	7.13	9.99	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	67.27	21.64	4.09	8.77	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	106.28	34.92	6.62	9.03	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	78.41	29.70	2.38	5.94	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	80.35	21.87	5.09	6.10	0.00	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	95.00	29.54	6.11	9.17	0.76	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	92.76	22.24	8.90	6.99	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	72.50	25.03	6.90	7.34	0.43	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	99.07	27.10	5.93	7.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	88.15	27.84	4.64	6.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	73.69	29.29	6.61	2.83	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	92.73	35.26	7.29	6.61	0.00	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	90.34	25.48	2.32	6.95	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	65.49	29.58	2.11	6.34	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	99.70	31.30	5.79	9.22	0.21	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	93.86	33.69	6.02	9.63	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	97.68	24.06	5.83	8.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	105.98	31.72	6.44	8.05	0.00	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	107.11	35.70	7.65	2.55	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	110.84	28.47	9.92	9.92	0.25	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	114.99	33.03	7.64	10.12	0.21	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	86.60	31.52	8.26	6.43	0.00	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	95.60	25.81	8.13	9.08	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	103.55	38.14	6.65	13.08	0.67	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	105.28	30.52	3.05	6.10	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	85.30	31.02	8.31	10.52	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	111.21	36.28	7.94	10.06	0.00	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	95.22	33.44	6.91	6.18	0.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	127.24	47.53	12.77	7.25	0.00	0.37
Astrocyte - cerebellum, donor2	11580-120F5	142.06	50.15	14.72	6.85	0.17	0.00
Astrocyte - cerebellum, donor3	11661-122F5	104.03	32.93	11.54	5.45	0.42	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	72.16	26.49	10.81	3.49	0.35	0.35
Astrocyte - cerebral cortex, donor2	11316-117D2	100.62	33.65	8.25	3.56	0.16	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	113.96	39.68	9.55	4.47	0.15	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	45.07	7.91	3.67	1.83	0.46	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	43.97	9.40	3.13	3.26	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	46.54	6.94	3.53	2.39	0.00	0.00
Basophils, donor1	12241-129G9	45.77	12.82	6.54	6.54	0.26	0.52
Basophils, donor2	12242-129H1	63.14	14.43	10.10	9.74	0.00	0.00
Basophils, donor3	12243-129H2	57.18	14.99	6.91	6.03	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	73.52	20.05	5.61	4.31	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	170.07	45.26	5.49	10.97	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	35.87	21.52	14.35	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	121.76	29.50	6.90	8.79	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	151.60	43.67	7.07	8.73	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	85.90	24.87	5.99	4.61	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	60.82	15.66	3.78	3.24	0.00	0.18
Burkitt's lymphoma cell line:DAUDI	10422-106C8	25.76	9.89	2.68	2.06	0.10	0.00
Burkitt's lymphoma cell line:RAJI	10476-106I8	42.39	7.45	3.73	3.49	0.00	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	58.20	20.79	11.51	4.80	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	82.74	10.34	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	38.32	10.71	6.76	5.64	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	49.93	12.99	7.61	5.20	0.37	0.19
CD14+ Monocytes, donor3	11381-118B4	45.88	10.10	5.49	2.63	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	70.48	15.00	5.09	2.55	0.57	0.85
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	67.48	17.82	6.07	2.65	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	70.68	15.12	3.62	2.96	0.00	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	61.29	12.00	3.32	5.06	0.43	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	44.05	12.07	2.72	3.02	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	50.70	12.08	1.42	5.92	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	47.88	13.39	2.85	3.68	0.17	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	41.95	12.70	1.38	5.24	0.00	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	58.02	23.55	2.73	5.21	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	54.63	12.73	2.55	4.11	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	43.27	10.68	1.60	2.67	0.36	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	48.53	15.02	2.18	4.13	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	40.27	13.11	3.75	1.64	0.00	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	42.77	13.73	2.64	4.22	0.00	0.53
CD14+ monocytes - treated with Candida, donor3	11888-125D7	39.94	15.53	5.55	3.33	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	54.74	15.32	1.93	3.57	0.30	0.30
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	48.69	14.17	3.59	5.39	0.80	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	48.09	12.91	3.96	6.04	0.21	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	55.37	17.85	2.29	2.75	0.23	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	35.06	14.25	2.71	3.17	0.00	0.90
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	41.46	13.53	1.31	3.49	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	50.03	13.99	3.77	2.96	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	47.63	11.34	3.66	4.19	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	51.76	15.15	4.63	5.89	0.42	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	56.40	20.76	2.76	4.59	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	43.33	16.20	1.41	3.17	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	47.38	16.23	2.63	3.95	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	45.86	15.17	2.09	3.66	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	29.36	13.01	3.35	2.97	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	37.51	13.36	2.59	3.45	0.22	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	46.68	18.43	4.91	2.87	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	25.03	13.21	2.09	3.71	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	32.25	15.31	1.86	1.62	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	34.87	4.58	1.31	1.96	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	37.19	8.32	1.62	2.31	0.23	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	34.01	6.50	2.38	2.38	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	59.95	10.74	4.67	4.52	0.31	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	49.77	10.48	4.72	2.62	0.17	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	44.59	11.59	2.90	3.79	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	36.23	6.38	1.79	1.02	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	36.45	7.25	2.42	1.32	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	29.27	6.74	2.32	2.53	0.00	0.21
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	34.55	12.19	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	29.15	4.75	5.42	0.68	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	24.85	6.21	5.18	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	30.38	12.26	3.20	4.80	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	32.16	13.94	4.29	1.61	0.54	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	30.18	7.02	5.62	1.40	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	38.43	4.71	4.71	0.00	0.00	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	23.73	13.18	2.64	1.32	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	20.55	8.22	15.62	3.29	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	17.41	10.88	13.78	1.45	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	15.65	11.11	11.61	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	42.43	26.67	7.68	0.81	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	47.94	27.56	8.79	0.80	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	41.17	11.04	4.02	5.02	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	64.61	19.66	9.55	9.55	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	66.51	21.04	6.76	6.76	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	65.16	15.33	9.02	5.86	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	37.13	17.14	26.42	4.64	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	32.46	18.98	38.58	3.67	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	45.44	30.50	35.99	3.66	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	61.26	11.23	9.19	4.59	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	66.26	10.11	10.56	3.37	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	69.57	13.51	13.22	4.60	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	36.51	15.65	16.59	1.42	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	28.09	12.64	25.99	1.40	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	42.85	13.18	16.48	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	93.93	16.62	11.27	10.26	1.01	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	94.56	24.74	11.35	8.81	0.34	0.34
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	88.34	21.12	11.12	12.25	0.16	0.64
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	48.42	20.17	21.97	4.03	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	48.56	16.77	19.22	3.84	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	47.96	13.64	15.40	3.96	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	66.20	13.07	11.38	4.64	0.42	0.84
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	78.12	18.28	8.31	8.52	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	78.19	16.71	8.02	7.35	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	21.75	14.41	25.02	1.09	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	21.44	17.69	25.73	1.07	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	8.97	16.14	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	101.24	22.07	15.58	8.90	0.00	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	89.90	25.78	13.65	9.10	0.22	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	85.95	21.02	13.87	10.51	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	49.55	21.74	14.16	3.54	0.00	0.51
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	43.33	17.33	20.80	3.90	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	35.30	11.33	18.74	2.61	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	56.91	19.79	16.83	3.46	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	54.47	24.93	14.77	6.46	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	48.85	25.12	12.56	5.58	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	55.11	17.45	16.89	4.71	0.28	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	55.46	19.14	18.40	5.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	84.70	20.02	23.10	9.24	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	60.16	20.05	17.55	4.66	0.36	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	56.78	19.39	24.93	8.31	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	97.24	40.60	21.61	19.64	0.33	0.00
CD8+ T Cells, donor2	11307-117C2	88.98	32.66	21.02	15.02	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	81.55	27.52	21.46	14.14	0.50	0.25
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	119.74	45.42	5.51	14.91	0.23	0.00
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	107.84	35.23	4.79	16.06	0.24	0.48
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	112.45	38.03	4.92	18.60	0.82	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	92.47	27.32	2.40	12.61	0.30	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	122.87	42.48	4.56	14.64	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	109.37	39.34	5.68	15.46	0.23	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	118.20	36.29	3.91	15.64	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	113.18	43.96	4.21	17.63	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	105.30	38.93	3.28	18.76	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	144.00	43.47	3.32	21.74	0.00	0.60
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	129.56	41.83	3.49	24.40	0.58	0.29
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	135.88	38.63	3.46	23.98	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	92.37	44.21	2.63	11.38	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	100.65	48.28	1.82	10.47	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	78.32	29.83	2.24	5.22	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	111.65	56.18	7.20	15.85	0.72	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	128.32	50.35	4.03	13.81	0.29	0.58
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	119.26	53.97	7.78	11.08	0.00	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	126.44	43.10	4.75	19.01	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	125.49	45.21	4.92	25.53	0.00	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	117.33	41.68	5.45	21.16	0.64	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	119.33	34.42	3.06	20.27	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	109.17	35.47	3.94	24.04	0.39	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	105.90	34.04	4.54	18.91	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	96.35	19.27	2.41	8.03	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	73.44	39.87	4.90	6.99	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	104.18	42.07	10.02	3.01	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	146.22	51.18	7.31	5.48	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	120.56	36.56	5.93	12.35	0.49	0.49
Cardiac Myocyte, donor3	11686-122I3	115.33	39.15	7.26	7.05	0.11	0.11
Chondrocyte - de diff, donor1	11261-116G1	120.64	42.99	10.40	9.01	1.39	0.69
Chondrocyte - de diff, donor2	11338-117F6	121.18	39.45	11.02	5.33	1.07	0.36
Chondrocyte - de diff, donor3	11410-118E6	90.00	28.67	8.76	5.58	0.68	0.11
Chondrocyte - re diff, donor2	11339-117F7	224.71	75.20	17.91	16.11	1.79	0.00
Chondrocyte - re diff, donor3	11411-118E7	164.59	68.75	16.98	7.68	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	88.71	21.00	6.66	6.08	0.11	0.00
Ciliary Epithelial Cells, donor2	11323-117D9	101.54	26.51	7.05	9.19	0.21	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	94.96	27.79	7.35	7.08	0.00	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	74.64	36.22	13.02	5.23	0.09	0.55
Corneal Epithelial Cells, donor1	11526-119I5	109.13	27.01	7.69	7.69	0.00	0.22
Corneal Epithelial Cells, donor2	11606-120I4	70.53	22.75	12.51	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	93.05	22.24	7.16	6.39	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	60.26	12.05	1.49	4.29	0.33	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	62.77	11.67	2.52	6.31	0.32	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	48.31	10.35	3.45	3.45	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	67.28	9.83	1.62	3.13	0.00	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	80.29	28.01	20.50	6.83	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	80.30	17.63	16.97	6.53	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	78.40	25.65	18.87	12.58	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	113.24	33.69	6.17	7.67	0.17	0.50
Endothelial Cells - Aortic, donor1	11263-116G3	102.10	19.95	3.52	8.80	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	120.75	36.20	6.22	9.90	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	121.10	29.10	8.65	7.08	0.39	0.00
Endothelial Cells - Artery, donor1	11264-116G4	109.08	29.38	2.91	9.02	0.00	0.29
Endothelial Cells - Artery, donor2	11341-117F9	104.93	25.88	4.24	11.76	0.24	0.71
Endothelial Cells - Artery, donor3	11413-118E9	146.91	34.54	5.79	12.97	0.53	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	68.27	15.74	4.88	6.21	0.22	0.22
Endothelial Cells - Lymphatic, donor2	11317-117D3	76.07	18.56	4.56	8.22	0.00	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	74.70	18.04	4.79	5.64	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	79.33	16.34	4.46	5.35	0.89	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	81.22	15.62	4.69	6.77	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	58.42	12.62	3.97	3.26	0.14	0.14
Endothelial Cells - Thoracic, donor1	11266-116G6	96.03	35.61	5.20	8.00	0.40	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	120.55	41.41	5.24	9.96	0.00	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	97.41	23.61	8.08	8.32	0.00	0.50
Endothelial Cells - Umbilical vein, donor2	11324-117E1	64.31	21.07	5.21	4.13	0.00	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	85.49	26.50	6.59	4.40	0.00	0.00
Endothelial Cells - Vein, donor1	11267-116G7	103.51	39.81	11.38	9.10	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	113.16	34.23	10.48	8.38	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	115.87	32.34	6.28	10.68	0.47	0.00
Eosinophils, donor1	12244-129H3	45.74	15.25	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	90.76	57.76	13.20	21.45	0.00	0.00
Eosinophils, donor3	12246-129H5	96.30	42.80	14.27	10.70	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	90.89	26.88	5.38	4.89	0.24	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	106.09	39.52	6.24	8.32	0.00	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	130.15	65.08	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	120.28	35.30	10.26	6.16	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	85.18	30.99	5.80	5.69	2.19	1.64
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	21.45	11.92	3.47	1.19	0.22	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	120.43	32.75	8.85	6.31	1.82	0.61
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	90.07	34.80	5.19	7.51	0.00	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	98.51	29.74	6.54	4.85	0.63	0.42
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	172.59	52.96	17.13	10.54	1.05	1.05
Fibroblast - Aortic Adventitial, donor3	11401-118D6	118.93	35.88	7.64	7.31	1.33	0.33
Fibroblast - Cardiac, donor1	11268-116G8	140.62	34.93	9.98	5.90	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	203.13	56.85	9.10	21.98	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	143.05	37.69	7.10	9.46	0.47	0.32
Fibroblast - Cardiac, donor4	11452-119A3	111.24	34.55	7.58	10.31	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	110.91	27.28	4.57	6.73	0.13	0.38
Fibroblast - Cardiac, donor6	11460-119B2	119.76	42.29	6.82	8.19	0.30	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	167.89	56.01	12.19	8.84	0.27	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	114.33	34.51	9.92	6.47	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	147.94	46.87	16.11	7.32	0.00	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	143.46	38.29	10.61	5.54	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	97.18	28.49	6.28	2.88	0.00	0.34
Fibroblast - Dermal, donor1	11269-116G9	81.00	25.12	7.75	3.29	0.00	0.23
Fibroblast - Dermal, donor2	11346-117G5	137.26	35.85	8.96	9.91	0.47	0.00
Fibroblast - Dermal, donor3	11418-118F5	104.81	24.30	5.92	6.53	0.00	0.73
Fibroblast - Dermal, donor4	11450-119A1	105.13	39.68	7.12	5.88	0.34	0.00
Fibroblast - Dermal, donor5	11454-119A5	107.46	38.90	9.42	7.33	0.35	0.17
Fibroblast - Dermal, donor6	11458-119A9	133.19	54.74	9.58	7.63	0.00	0.16
Fibroblast - Gingival, donor1	11237-116D4	112.65	31.65	10.00	5.83	0.21	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	119.21	49.26	10.48	7.34	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	117.29	35.32	8.83	5.40	0.00	0.13
Fibroblast - Gingival, donor3	11394-118C8	93.59	21.17	6.19	4.16	0.10	0.19
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	128.82	36.36	6.23	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	90.92	28.72	9.87	3.88	0.88	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	175.54	67.97	15.43	9.98	0.00	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	130.63	48.41	8.25	9.20	0.00	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	103.39	52.58	8.82	10.23	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	117.00	44.75	13.60	8.34	0.29	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	128.58	54.54	10.77	11.45	0.14	0.41
Fibroblast - Gingival, donor8 (control)	11926-125H9	163.44	62.09	11.63	11.41	0.00	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	92.30	36.68	12.77	4.55	0.15	0.15
Fibroblast - Lung, donor1	11270-116H1	108.75	21.75	6.80	5.44	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	94.01	29.84	8.95	5.97	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	109.95	38.20	12.24	5.91	0.00	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	239.91	94.96	19.99	15.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	109.09	48.95	5.59	6.99	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	152.81	43.38	12.31	7.84	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	252.51	81.60	14.21	17.05	0.41	0.41
Fibroblast - Mammary, donor2	11620-122A9	179.74	71.90	15.98	0.00	3.99	0.00
Fibroblast - Mammary, donor3	11701-123A9	172.73	53.61	5.96	11.91	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	120.65	42.48	9.70	7.18	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	120.28	41.56	11.07	5.61	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	131.27	41.61	8.26	9.79	0.00	0.31
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	112.20	41.22	9.92	6.11	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	140.93	39.96	9.99	9.99	0.00	0.27
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	121.42	40.47	9.97	4.64	0.12	0.35
Fibroblast - Pulmonary Artery, donor1	11250-116E8	139.38	51.29	8.07	11.16	0.00	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	227.17	108.10	23.77	21.94	0.00	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	125.62	40.76	15.37	11.36	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	102.40	35.98	7.91	6.33	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	171.86	57.55	14.09	14.09	0.40	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	100.71	33.21	8.53	5.51	0.18	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	121.01	41.39	10.25	8.08	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	219.62	72.81	18.65	16.85	1.20	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	120.47	42.75	6.80	6.26	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	87.06	28.60	6.33	7.59	0.25	0.00
Fibroblast - skin normal, donor1	11553-120C5	126.83	48.73	13.62	7.55	0.33	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	202.71	69.98	12.83	14.64	0.20	0.00
Fibroblast - skin normal, donor2	11561-120D4	133.01	40.99	8.34	10.45	0.70	0.50
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	117.87	41.10	8.76	8.46	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	105.55	33.72	8.20	5.80	0.50	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	83.59	30.60	7.86	4.10	0.00	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	214.79	57.15	20.03	14.12	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	144.34	49.96	12.14	12.78	0.32	0.53
Fibroblast - skin walker warburg, donor1	11554-120C6	158.56	71.01	12.48	12.15	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	77.31	18.98	3.61	4.70	0.78	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	0.00	0.00	22.16	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	42.71	13.94	6.10	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	102.63	28.78	3.81	12.14	0.17	0.35
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	114.77	35.91	3.90	13.79	0.52	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	85.60	28.36	2.56	5.88	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	97.23	30.62	8.42	3.83	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	98.26	24.25	6.38	7.66	0.64	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	82.44	17.69	7.99	3.42	0.86	1.71
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	64.25	18.75	8.27	1.10	1.10	4.41
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	45.67	21.46	13.47	1.37	1.37	2.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	71.13	21.40	9.11	5.55	0.79	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	58.42	15.86	7.67	3.17	0.79	3.97
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	53.81	21.53	10.44	1.96	0.00	1.96
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	68.10	18.57	6.19	3.98	0.44	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	81.68	28.97	7.63	6.50	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	71.92	30.05	6.65	4.19	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	57.22	15.04	6.45	4.30	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	71.24	23.17	5.95	5.20	0.62	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	64.09	22.01	6.64	3.60	0.42	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	59.57	19.92	5.90	5.29	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	72.33	18.25	5.93	5.25	0.00	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	62.53	18.93	5.61	4.86	0.12	0.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	65.79	22.51	9.62	3.72	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	77.12	29.55	7.09	3.25	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	63.11	22.10	6.36	6.20	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	81.32	27.93	6.26	3.13	0.22	0.22
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	63.11	21.57	8.87	4.44	0.60	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	74.13	27.14	5.43	5.09	0.34	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	94.61	33.61	7.54	6.83	0.53	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	77.73	24.35	6.87	3.64	0.52	0.31
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	76.68	25.10	6.83	4.95	0.68	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	74.25	23.13	5.98	4.87	0.00	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	88.94	29.87	7.65	6.07	0.50	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	84.33	27.16	6.94	3.88	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	79.43	20.42	9.28	4.75	0.21	0.62
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	78.40	25.36	6.23	3.00	0.23	0.12
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	84.22	24.18	5.84	6.34	0.83	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	67.67	18.96	6.17	1.76	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	77.73	27.55	5.29	4.80	0.37	0.37
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	88.18	26.10	6.16	4.54	0.32	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	77.93	22.45	8.98	3.85	0.64	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	73.15	20.56	5.69	4.83	0.19	0.28
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	70.55	18.82	5.06	4.90	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	71.46	23.41	7.60	6.08	0.91	1.52
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	85.09	24.36	5.33	8.15	0.21	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	73.33	21.08	4.61	5.05	0.22	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	77.43	20.76	6.73	5.61	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	92.86	24.81	5.18	8.70	0.09	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	106.96	29.41	6.69	5.35	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	106.34	30.91	5.36	13.16	0.31	0.77
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	99.87	27.72	3.89	10.23	0.26	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	103.28	26.02	5.69	10.30	0.54	0.54
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	99.92	25.81	6.08	7.74	0.37	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	89.04	23.91	6.14	6.80	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	69.42	14.88	5.95	2.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	100.78	31.13	6.73	6.07	0.13	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	110.97	31.07	7.06	4.84	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	82.35	28.72	7.37	4.07	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	75.24	21.30	7.96	4.78	0.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	62.71	25.88	6.01	3.85	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	71.40	25.37	10.02	5.73	0.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	92.63	25.66	10.64	5.32	0.00	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	91.83	28.82	10.45	5.37	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	65.95	18.45	11.99	4.61	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	64.34	19.80	12.37	4.95	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	66.53	22.82	5.80	6.19	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	86.64	41.72	12.84	1.60	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	81.72	26.08	5.22	6.96	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	77.79	34.18	7.81	4.23	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	75.36	32.94	7.82	4.94	0.41	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	63.31	36.65	10.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	76.34	36.63	7.83	7.27	1.12	1.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	92.82	37.26	7.84	2.94	0.98	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	75.50	26.00	6.71	4.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	84.61	34.67	10.81	2.86	0.95	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	91.71	38.38	8.83	3.06	0.34	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	77.26	29.23	6.26	6.26	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	91.63	34.36	8.59	6.30	1.15	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	83.17	34.04	8.58	2.37	0.59	0.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	103.34	40.66	3.39	11.86	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	82.84	39.35	7.04	5.38	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	77.55	30.61	8.28	4.37	0.46	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	68.49	68.49	5.27	5.27	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	82.65	46.13	10.76	4.61	0.77	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	79.21	34.23	8.48	1.96	2.28	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	85.61	38.12	7.36	4.01	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	94.39	40.45	7.71	2.31	1.54	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	124.95	53.06	7.53	7.87	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	86.97	29.82	12.42	2.48	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	69.36	27.37	6.61	4.72	0.00	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	73.02	33.19	12.07	4.22	0.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	77.83	31.54	9.66	3.05	0.51	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	77.37	35.10	9.57	4.39	1.20	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	92.75	36.01	8.39	2.47	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	94.44	41.32	12.98	1.18	0.00	1.18
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	93.93	29.17	7.58	1.17	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	108.40	61.00	10.53	1.76	2.19	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	64.42	37.30	11.87	2.54	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	91.33	27.46	7.16	1.19	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	66.96	26.20	8.73	4.37	0.00	0.49
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	203.15	59.35	10.27	18.26	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	111.85	37.84	7.07	9.15	0.83	0.83
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	240.63	65.22	22.49	19.12	0.00	3.37
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	79.92	22.20	7.93	5.39	0.32	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	81.88	22.56	7.52	10.86	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	66.38	20.89	3.37	3.25	0.00	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	64.99	17.22	3.88	4.56	0.00	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	63.93	20.93	4.32	4.55	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	64.60	19.68	3.50	3.61	0.00	0.11
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	68.99	26.00	3.87	1.93	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	68.24	21.96	5.60	4.52	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	70.11	21.54	2.62	4.61	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	57.98	20.07	3.43	4.12	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	53.82	21.14	2.24	4.49	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	72.75	19.59	4.48	4.48	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	160.57	44.14	10.82	14.71	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	58.16	37.01	7.93	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	201.76	71.25	13.05	19.75	0.35	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	175.09	59.57	13.80	10.90	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	148.26	44.58	9.44	16.96	0.35	0.35
Hepatocyte, donor1	11523-119I2	205.80	55.69	3.63	31.48	1.21	0.00
Hepatocyte, donor2	11603-120I1	187.46	44.17	1.08	26.93	1.08	1.08
Hepatocyte, donor3	11684-122I1	199.40	52.15	6.14	31.29	0.00	1.23
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	46.99	18.28	16.32	1.96	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	124.27	63.80	7.17	9.79	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	97.28	30.73	5.21	6.59	0.00	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	57.31	35.02	19.10	9.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	80.10	26.70	20.03	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	54.17	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	89.98	26.30	13.84	1.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	87.59	12.51	22.52	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	47.47	35.60	11.87	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	102.52	17.94	7.69	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	118.84	41.14	4.57	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	100.71	37.36	9.75	6.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	103.37	30.01	3.33	5.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	25.41	14.52	7.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	95.29	27.79	7.94	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	89.80	31.04	12.20	2.22	1.11	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	99.53	36.67	26.19	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	73.06	35.27	11.34	6.30	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	105.17	29.39	17.01	7.73	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	131.71	43.90	14.63	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	72.36	21.97	10.98	5.17	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	83.72	32.20	12.88	4.83	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	131.43	47.79	23.90	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	98.60	26.08	10.59	3.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	112.51	33.58	7.56	7.98	0.00	0.84
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	114.98	28.74	14.37	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	97.25	27.33	9.64	3.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	94.17	35.08	10.16	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	89.69	34.46	7.55	8.50	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	87.98	14.51	9.98	4.53	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	73.71	29.48	29.48	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	94.70	21.52	6.46	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	111.80	30.49	11.43	6.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	131.44	32.86	32.86	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	91.19	26.14	7.65	7.01	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	96.60	38.28	9.11	7.29	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	89.97	25.71	10.00	5.00	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	86.28	23.23	6.64	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	91.05	31.48	8.33	6.17	0.31	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	84.29	24.58	10.54	7.02	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	88.01	18.86	6.29	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	69.54	31.99	7.65	4.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	79.67	8.85	8.85	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	94.02	35.66	9.73	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	78.47	23.54	13.08	2.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	80.99	27.00	11.25	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	62.72	31.36	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	72.54	18.14	7.47	6.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	59.57	30.48	8.31	5.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	62.69	19.95	8.55	11.40	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	74.55	23.93	10.12	7.36	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	87.73	9.08	6.05	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	43.46	12.42	6.21	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	66.61	16.92	6.34	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	74.50	19.58	5.30	4.49	0.16	0.41
Keratinocyte - epidermal, donor2	11349-117G8	91.36	18.74	3.51	5.27	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	102.32	26.69	3.69	6.53	0.28	0.00
Keratinocyte - oral, donor1	11251-116E9	92.40	24.97	7.04	4.09	0.11	0.00
Keratocytes, donor1	11527-119I6	188.08	48.14	12.72	7.56	0.34	0.34
Keratocytes, donor2	11607-120I5	152.33	49.22	10.55	9.37	0.00	0.00
Keratocytes, donor3	11688-122I5	85.95	21.93	7.31	3.56	0.20	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	50.55	37.36	10.99	4.40	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	69.04	26.97	7.55	4.31	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	82.92	19.15	7.04	3.11	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	130.07	34.51	6.46	9.38	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	67.47	17.43	4.74	4.98	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	48.28	13.95	5.30	4.74	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	61.08	12.28	4.88	5.35	0.31	0.47
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	40.87	12.37	3.23	4.84	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	50.43	9.77	4.41	4.10	0.95	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	54.88	11.10	3.77	4.10	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	47.61	8.21	3.69	3.69	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	59.92	12.39	4.30	3.54	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	51.66	8.73	3.80	3.80	0.28	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	37.97	13.05	3.96	3.56	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.38	15.32	4.46	5.43	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	60.91	7.59	3.89	4.63	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	48.08	11.15	2.44	2.79	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	49.37	12.40	3.10	3.58	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	54.80	11.67	4.67	4.12	0.14	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	53.28	15.40	4.00	4.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	51.75	11.22	4.68	4.05	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	65.88	14.09	4.94	2.38	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	46.40	13.16	4.94	2.63	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	53.60	8.79	6.74	2.64	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	67.21	13.69	5.73	4.23	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	44.62	9.70	1.94	4.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	52.51	12.66	6.73	2.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	52.07	10.29	3.78	4.09	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	47.69	14.00	5.18	4.15	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	60.30	10.47	4.40	4.40	0.00	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	55.34	12.63	4.81	2.71	0.00	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	54.34	17.88	5.50	7.57	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	55.32	15.99	3.39	3.39	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	51.53	11.88	4.14	3.71	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	42.64	12.11	4.36	2.42	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	55.57	12.90	2.98	4.30	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	60.46	13.01	3.59	3.59	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	59.60	14.81	4.07	4.07	0.37	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	56.09	14.58	4.69	3.21	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	55.00	11.55	3.57	2.61	0.27	0.41
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	57.89	12.54	3.86	3.54	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	56.61	12.48	5.17	2.43	0.00	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	58.09	12.32	4.06	2.52	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	43.38	13.87	3.56	3.91	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	56.23	16.00	6.30	4.36	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	62.40	12.45	4.67	4.05	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	60.16	13.25	3.94	4.66	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	68.27	15.68	2.94	2.61	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	51.32	9.89	4.47	7.06	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	73.51	18.56	5.82	6.06	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	47.64	14.09	4.61	2.82	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	44.75	12.23	2.69	5.37	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	92.91	29.46	2.27	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	79.78	20.71	3.84	7.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	68.28	25.24	2.97	4.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	78.28	27.50	4.23	3.81	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	82.29	22.51	4.22	7.03	0.70	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	57.91	29.89	7.47	8.41	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	63.89	25.25	3.09	5.67	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	76.13	21.41	4.76	11.89	0.00	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	76.91	27.14	5.88	5.88	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	61.36	22.39	4.07	3.78	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	66.63	23.86	1.35	8.10	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	99.99	34.28	5.42	5.42	0.14	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	72.41	21.57	7.19	4.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	81.51	28.58	4.94	5.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	61.97	17.32	3.33	4.00	1.33	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	77.43	27.00	5.09	4.08	0.00	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	76.84	28.55	4.54	8.54	0.00	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	75.77	29.85	4.53	4.72	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	67.49	31.91	4.29	5.52	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	90.51	38.32	4.89	10.60	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	78.09	27.28	4.79	8.54	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	82.96	25.50	3.64	6.17	0.28	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	84.49	29.88	2.06	11.33	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	85.93	23.51	5.81	5.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	78.62	33.18	6.58	4.78	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	80.22	24.34	4.43	3.32	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	84.48	30.40	4.95	4.95	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	72.65	27.66	5.16	4.79	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	92.10	25.33	2.30	5.76	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	89.80	27.25	3.45	7.68	0.38	0.77
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	63.41	23.21	6.79	4.53	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	83.69	30.36	4.10	8.20	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	98.51	35.70	5.87	8.13	1.36	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	75.41	31.60	0.72	4.31	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	78.42	38.09	5.98	5.98	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	91.04	27.13	4.83	8.18	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	83.13	27.57	4.31	7.75	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	80.49	25.69	6.85	8.56	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	83.63	26.99	5.66	10.33	0.33	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	86.88	30.77	9.05	1.21	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	78.21	39.10	4.98	3.55	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	74.93	29.22	5.50	4.12	0.69	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	79.44	36.50	6.44	5.90	1.61	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	77.44	33.67	2.69	2.02	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	67.04	37.41	4.07	5.93	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	72.10	30.24	2.33	3.49	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	66.64	28.56	2.12	9.52	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	76.03	33.61	4.40	4.80	0.00	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	77.78	40.70	5.81	4.36	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	101.95	36.03	4.60	3.07	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	79.42	33.54	4.44	7.89	0.49	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	79.98	22.58	7.53	4.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	111.12	27.15	3.02	6.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	79.31	26.59	7.21	5.86	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	68.84	30.98	6.88	6.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	89.07	27.61	5.34	5.34	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	77.03	27.76	6.26	6.65	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	81.15	27.71	5.94	7.26	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	96.00	30.10	4.15	8.30	0.00	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	83.14	32.38	5.25	5.25	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	85.54	36.90	4.47	5.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	88.77	31.80	6.18	5.74	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	81.00	29.70	3.47	5.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	81.52	29.37	5.57	4.56	0.51	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	84.11	33.64	5.29	8.65	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	86.27	31.01	7.55	5.57	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	74.13	31.60	5.47	6.08	0.61	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	66.40	16.60	5.53	9.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	82.08	34.96	7.22	9.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	88.31	37.18	7.23	7.23	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	60.47	21.16	4.23	7.86	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	81.76	27.89	7.61	8.87	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	79.43	30.39	3.73	6.93	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	73.56	29.31	5.17	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	84.33	31.88	3.60	6.17	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	80.64	35.37	4.95	8.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	71.50	42.56	3.40	5.11	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	82.37	29.54	7.90	4.99	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	74.39	30.54	3.92	13.31	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	81.42	25.05	2.51	4.59	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	84.56	30.67	7.43	8.36	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	72.93	27.43	4.01	6.02	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	84.47	38.49	5.88	5.35	0.00	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	96.98	36.77	4.85	2.83	1.21	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	92.69	33.96	7.34	5.51	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	88.02	35.56	8.00	8.89	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	95.17	36.47	4.56	10.26	0.57	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	96.63	35.28	6.14	9.20	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	74.42	32.28	7.11	3.83	0.00	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	102.01	45.44	8.02	6.68	0.00	0.45
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	112.30	53.03	8.06	8.06	0.52	0.26
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	80.90	39.12	8.62	3.98	0.66	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	101.85	47.81	16.63	10.39	0.00	2.08
Macrophage - monocyte derived, donor1	11232-116C8	69.06	16.41	3.42	2.51	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	83.68	20.37	3.67	4.77	0.00	0.37
Macrophage - monocyte derived, donor3	11389-118C3	89.40	23.73	3.01	4.72	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	79.65	28.68	2.66	9.56	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	111.39	30.74	4.44	13.94	0.79	0.48
Mallassez-derived cells, donor3	11930-125I4	99.51	25.71	2.92	11.40	0.00	0.42
Mammary Epithelial Cell, donor1	11273-116H4	75.53	18.33	6.88	4.48	0.10	0.00
Mammary Epithelial Cell, donor2	11350-117G9	82.52	22.87	4.63	4.05	0.00	0.00
Mammary Epithelial Cell, donor3	11422-118F9	99.52	23.45	4.74	3.99	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	69.15	18.30	2.03	4.07	0.00	0.00
Mast cell, donor1	11563-120D6	84.35	20.01	6.70	9.73	0.32	0.54
Mast cell, donor2	11565-120D8	57.95	32.39	18.42	2.67	0.89	0.59
Mast cell, donor3	11566-120D9	47.28	34.22	18.91	3.60	0.68	0.45
Mast cell, donor4	11567-120E1	56.38	34.22	13.83	3.01	0.71	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	105.90	24.73	8.10	11.20	0.00	0.33
Mast cell, expanded and stimulated, donor8	11942-126A7	112.07	27.43	9.34	23.93	1.75	1.17
Mast cell, expanded, donor5	11939-126A4	76.98	18.01	8.15	5.05	0.46	0.80
Mast cell, expanded, donor8	11941-126A6	83.52	17.57	5.86	12.22	1.00	1.00
Melanocyte - dark, donor1	11502-119F8	82.19	15.62	4.68	4.38	0.00	0.10
Melanocyte - dark, donor2	11582-120F7	126.32	32.19	7.96	10.38	0.35	0.00
Melanocyte - dark, donor3	11663-122F7	109.97	29.05	5.29	6.95	0.00	0.29
Melanocyte - light, donor1	11274-116H5	86.74	19.04	2.12	5.64	0.94	0.71
Melanocyte - light, donor2	11351-117H1	85.31	21.84	4.09	10.92	0.00	0.00
Melanocyte - light, donor3	11423-118G1	95.39	16.48	7.81	6.07	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	96.21	31.86	4.17	5.62	0.31	0.52
Melanocyte, donor2 (MC+2)	12739-135I3	112.69	22.59	2.15	9.95	0.54	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	60.54	11.25	3.75	3.21	0.54	0.27
Meningeal Cells, donor1	11493-119E8	143.91	40.32	11.41	12.16	0.50	0.00
Meningeal Cells, donor2	11573-120E7	144.37	47.98	12.76	8.36	0.44	0.44
Meningeal Cells, donor3	11654-122E7	110.19	35.13	10.19	8.39	0.08	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	108.93	37.36	7.98	6.84	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	116.63	41.66	6.84	10.77	0.00	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	147.19	43.37	7.88	7.88	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	172.68	45.79	10.47	24.86	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	163.61	52.39	6.46	18.66	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	107.37	40.45	8.89	5.08	0.42	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	91.98	36.19	11.56	3.52	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	208.99	86.14	16.70	16.70	0.22	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	146.12	44.57	6.58	14.61	0.73	0.73
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	190.69	68.75	16.37	15.35	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	107.48	36.70	8.86	6.37	0.00	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	223.78	56.50	15.24	15.61	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	136.71	45.26	10.39	5.66	0.39	0.00
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	185.76	45.40	8.90	9.20	0.59	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	135.46	21.02	2.34	4.67	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	203.01	55.07	11.53	16.01	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	178.29	58.84	11.70	20.56	0.35	0.35
Mesenchymal stem cells - hepatic, donor0	11218-116B3	132.91	42.22	5.00	5.63	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	154.57	51.52	9.43	8.71	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	97.05	36.59	5.57	5.04	0.53	0.00
Mesothelial Cells, donor2	12156-128G5	105.60	30.53	8.51	9.01	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	92.86	23.99	3.61	4.41	0.22	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	51.31	13.50	4.05	2.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	67.73	16.75	4.43	2.71	0.00	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	71.55	15.02	4.42	3.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	89.88	17.29	0.00	6.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	45.87	9.30	5.27	3.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	54.76	14.52	4.15	2.07	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	57.90	11.58	9.26	2.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	62.06	14.01	2.50	2.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	52.60	19.08	1.86	2.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	19.47	19.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	49.58	11.99	2.44	1.83	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.58	16.23	3.17	4.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	59.86	51.31	0.00	8.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	38.05	5.31	2.65	1.77	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	64.97	16.72	0.76	1.52	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	53.95	14.47	2.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	43.29	8.28	2.76	2.55	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	41.44	9.21	3.68	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	44.41	8.64	1.79	2.98	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	40.24	23.47	5.03	1.68	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	43.91	9.03	2.01	2.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	48.25	11.41	2.61	2.61	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	47.00	15.48	1.66	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	49.27	11.51	3.22	2.30	0.46	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	57.63	12.20	2.73	1.89	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	47.29	14.06	1.63	2.85	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	43.98	10.73	3.22	1.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	49.79	13.34	2.22	1.78	0.00	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	134.14	30.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	40.08	10.73	2.63	1.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	47.15	11.15	4.56	3.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	92.79	18.23	8.28	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	39.14	11.69	2.72	1.36	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	44.99	14.41	4.12	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	37.07	10.90	3.27	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	49.50	13.94	1.92	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	52.43	16.01	4.00	4.80	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	53.48	32.91	4.11	2.74	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	58.07	20.02	4.51	4.51	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	34.65	20.39	6.12	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	60.87	16.20	5.69	5.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	58.49	14.35	3.31	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	66.60	21.13	2.56	2.56	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	57.52	17.35	3.72	4.21	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	47.32	20.88	6.26	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	55.25	33.15	6.63	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	55.04	12.31	2.39	4.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	46.82	10.94	3.94	3.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	36.57	17.04	2.13	2.49	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	58.92	13.19	2.52	3.09	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	57.77	14.96	2.08	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	47.79	18.65	2.33	3.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	47.66	12.07	1.21	2.41	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	52.59	7.10	3.76	4.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	64.97	21.66	7.22	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	43.41	12.93	5.54	0.00	0.00	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	54.07	11.38	2.85	2.28	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	42.70	10.36	1.24	2.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	49.24	10.63	2.85	2.07	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	59.63	9.87	2.14	3.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	48.27	15.88	1.27	2.54	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	39.23	4.27	1.60	1.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	68.55	21.25	4.19	4.79	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	38.56	10.88	1.41	2.83	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	44.59	8.92	1.59	1.91	0.32	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	59.48	14.37	1.77	2.87	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	45.50	12.51	1.52	1.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	38.64	8.52	2.27	1.42	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	60.47	12.29	1.72	3.20	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	48.88	15.64	1.30	3.91	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	50.28	8.23	2.35	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	65.74	18.16	2.88	4.90	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	53.17	10.72	3.71	1.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	45.86	8.93	2.68	2.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	41.44	3.77	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	12.48	3.56	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	62.76	13.14	2.30	2.30	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	61.01	11.57	2.10	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	47.84	14.04	3.36	2.37	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	50.29	26.08	8.38	1.86	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	36.05	6.76	4.13	1.88	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	57.53	12.78	2.40	3.20	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	50.67	13.35	3.28	2.60	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	66.31	16.94	3.68	0.00	0.74	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	56.06	17.22	5.13	1.10	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	46.67	14.00	0.00	3.11	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	19.24	3.74	3.21	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	34.78	7.73	0.00	3.86	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	66.66	19.19	1.01	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	32.89	8.01	2.11	3.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	5.45	9.53	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	5.72	1.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	4.05	2.43	0.00	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	4.53	0.00	1.51	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	68.52	97.07	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	45.67	55.46	3.26	3.26	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	47.52	38.02	14.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	75.29	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	124.74	45.67	10.34	7.97	0.00	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	54.35	16.20	8.36	1.05	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	88.78	33.37	11.35	5.34	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	95.58	35.48	15.86	3.76	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	53.05	11.60	6.46	3.04	0.00	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	114.90	38.30	22.34	3.19	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	72.07	29.24	12.24	4.08	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	23.89	5.51	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	60.27	22.60	3.77	4.19	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	92.74	32.08	12.55	4.18	0.00	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	70.26	26.48	10.27	2.43	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	72.95	29.01	9.46	3.78	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	22.27	11.13	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	68.99	28.79	7.45	2.48	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	43.58	12.18	5.68	1.62	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	77.30	26.07	9.52	4.76	0.00	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	67.61	24.99	8.98	3.59	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	76.73	20.23	6.01	4.56	0.18	0.18
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	56.23	25.99	7.96	3.71	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	84.64	23.41	6.60	5.40	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	23.96	6.24	0.98	1.97	0.33	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	67.16	22.12	7.81	3.90	0.00	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	63.85	19.23	7.06	3.17	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	73.84	25.32	11.25	0.70	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	62.06	16.09	8.73	2.76	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	87.08	32.13	7.71	5.46	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	40.35	2.76	1.72	2.07	0.34	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	30.34	2.53	2.53	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	66.17	21.39	7.13	4.01	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	57.16	20.32	5.93	2.12	0.00	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	40.35	9.49	4.98	1.66	0.24	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	110.32	36.06	7.30	6.44	0.00	0.86
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	86.30	34.66	10.33	2.67	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.53	29.31	13.98	5.41	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	72.22	21.82	10.71	3.57	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	68.72	30.65	14.86	5.57	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	75.67	24.97	7.57	2.27	0.38	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	82.77	41.39	6.52	5.87	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	89.77	38.78	16.12	0.87	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	69.20	29.40	4.98	4.07	0.00	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	77.61	32.63	1.76	1.76	0.00	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	71.80	33.24	11.30	6.65	0.66	1.33
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	100.70	39.68	9.92	3.97	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	95.71	40.20	11.10	5.36	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	135.50	32.36	10.28	4.54	0.91	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	73.60	22.99	5.97	5.53	0.22	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	71.15	24.40	6.78	4.07	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	0.00	5.11	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	105.47	46.34	8.54	2.44	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	91.59	33.36	12.90	3.78	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	62.95	29.36	8.17	2.12	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	87.03	22.94	6.33	3.16	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	34.01	3.40	1.13	0.00	0.00	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	65.75	5.06	0.00	5.06	0.00	0.00
Myoblast, donor1	11241-116D8	133.67	48.95	7.21	13.29	0.37	0.37
Myoblast, donor2	11322-117D8	121.98	40.08	11.51	7.48	0.58	0.38
Myoblast, donor3	11398-118D3	120.24	43.55	10.93	9.42	0.17	0.17
NK T cell leukemia cell line:KHYG-1	10777-110G3	100.11	33.42	5.25	9.92	0.15	0.00
Natural Killer Cells, donor1	11230-116C6	84.87	21.53	12.92	20.91	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	73.28	22.32	16.59	11.76	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	78.78	21.17	12.88	14.17	0.00	0.00
Neural stem cells, donor1	11275-116H6	82.75	19.96	5.81	3.99	1.09	1.45
Neural stem cells, donor2	11352-117H2	50.07	21.18	13.48	0.00	0.00	0.00
Neurons, donor1	11494-119E9	67.14	22.76	17.07	2.28	1.14	0.00
Neurons, donor2	11574-120E8	64.29	29.50	15.41	2.20	0.00	0.00
Neurons, donor3	11655-122E8	55.91	25.49	14.80	1.64	0.00	0.00
Neutrophils, donor1	11233-116C9	31.55	10.21	3.71	2.78	0.00	0.93
Neutrophils, donor2	11314-117C9	28.99	31.89	5.80	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	44.59	18.94	10.38	3.67	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	105.44	31.11	12.23	3.56	0.12	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	84.33	21.49	8.79	3.91	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	83.63	31.49	8.22	4.61	0.00	0.20
Olfactory epithelial cells, donor1	11933-125I7	65.94	21.20	5.78	2.75	0.00	0.14
Olfactory epithelial cells, donor2	11934-125I8	84.82	27.36	9.41	4.20	0.29	0.29
Olfactory epithelial cells, donor3	11935-125I9	63.90	21.45	7.49	2.50	0.11	0.45
Olfactory epithelial cells, donor4	11936-126A1	79.77	28.15	7.01	3.41	0.10	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	119.76	39.12	6.62	6.02	0.60	0.00
Osteoblast - differentiated, donor1	11276-116H7	111.66	38.07	9.57	8.30	0.64	0.21
Osteoblast - differentiated, donor2	11353-117H3	83.45	19.43	9.14	6.86	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	89.38	22.35	7.45	6.83	0.00	0.62
Osteoblast, donor1	11277-116H8	213.03	61.17	13.88	14.85	0.00	0.78
Osteoblast, donor2	11354-117H4	203.67	66.02	16.86	21.77	0.00	0.00
Osteoblast, donor3	11426-118G4	239.76	86.38	20.44	12.09	0.36	0.36
Pancreatic stromal cells, donor1	11249-116E7	100.32	34.28	7.75	6.32	1.52	0.67
Pericytes, donor1	11491-119E6	127.73	30.26	11.46	5.67	0.45	1.34
Pericytes, donor2	11571-120E5	127.22	31.01	11.77	7.24	0.45	0.00
Pericytes, donor3	11652-122E5	191.24	63.07	12.21	16.07	0.00	0.00
Perineurial Cells, donor1	11499-119F5	118.67	41.14	11.53	7.12	0.11	0.00
Perineurial Cells, donor2	11579-120F4	142.43	39.75	6.26	9.94	0.37	0.37
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	47.17	14.02	17.53	7.33	0.00	0.64
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	41.63	8.57	10.04	4.65	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	54.35	17.21	12.04	6.08	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	85.14	55.01	9.57	4.78	0.00	0.72
Placental Epithelial Cells, donor2	11355-117H5	103.13	32.16	17.74	2.22	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	89.53	39.27	9.62	3.73	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	128.48	46.20	8.54	9.49	1.27	0.63
Preadipocyte - breast, donor1	11467-119B9	110.68	35.83	10.13	6.75	0.38	0.56
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	90.85	30.54	6.13	7.31	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	149.05	45.48	10.36	9.91	1.13	0.00
Preadipocyte - omental, donor1	11468-119C1	121.48	42.94	9.16	8.21	0.64	0.32
Preadipocyte - omental, donor2	11329-117E6	126.58	38.85	9.17	12.22	0.44	0.44
Preadipocyte - omental, donor3	11403-118D8	166.60	56.73	9.17	9.74	0.43	0.14
Preadipocyte - perirenal, donor1	11469-119C2	157.48	60.04	4.92	10.83	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	257.06	96.43	14.13	20.27	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	180.97	68.71	18.59	14.17	0.18	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	174.37	63.18	12.94	14.47	1.19	0.85
Preadipocyte - visceral, donor1	11280-116I2	148.01	52.07	11.55	11.18	0.19	1.21
Preadipocyte - visceral, donor2	11357-117H7	120.11	45.56	13.81	7.36	0.92	1.38
Preadipocyte - visceral, donor3	11429-118G7	124.45	45.56	9.20	9.20	0.21	0.63
Prostate Epithelial Cells (polarized), donor1	11253-116F2	130.79	75.58	6.34	9.65	2.41	3.02
Prostate Epithelial Cells, donor2	11331-117E8	94.65	32.23	5.01	8.12	0.95	1.35
Prostate Epithelial Cells, donor3	11404-118D9	45.81	20.15	5.08	2.20	0.24	0.31
Prostate Stromal Cells, donor1	11254-116F3	165.04	69.82	15.60	11.28	1.14	0.46
Prostate Stromal Cells, donor2	11332-117E9	161.19	62.58	14.70	10.94	0.54	0.36
Prostate Stromal Cells, donor3	11405-118E1	114.39	36.39	11.05	6.36	1.98	0.63
Renal Cortical Epithelial Cells, donor1	11516-119H4	104.75	21.53	7.30	7.30	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	71.11	18.71	5.41	2.77	0.00	0.14
Renal Epithelial Cells, donor1	11517-119H5	185.14	53.77	12.17	11.16	0.51	0.51
Renal Epithelial Cells, donor2	11597-120H4	124.48	39.83	8.54	14.94	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	92.95	17.47	6.35	5.08	0.11	0.11
Renal Glomerular Endothelial Cells, donor1	11514-119H2	89.87	32.68	7.49	10.21	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	100.40	27.63	5.39	5.93	0.00	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	90.58	23.31	6.88	7.10	0.22	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	112.46	25.29	11.31	14.64	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	167.93	42.26	14.97	11.88	0.22	0.00
Renal Mesangial Cells, donor2	11598-120H5	127.28	28.84	16.30	8.15	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	124.56	35.79	9.71	5.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	136.36	36.51	6.98	11.27	0.27	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	80.96	20.66	4.22	7.17	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	146.18	32.78	7.14	7.14	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	94.12	34.23	7.00	3.89	0.26	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	101.48	26.43	4.26	5.40	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	103.94	36.02	6.17	7.20	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	58.46	14.80	4.52	2.01	0.25	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	91.54	34.75	4.41	9.49	0.27	0.53
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	84.87	26.80	13.40	4.47	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	29.72	8.81	2.20	1.10	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	37.70	13.34	3.48	1.16	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	86.34	28.87	7.02	4.29	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	95.93	33.66	8.44	3.18	0.10	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	126.26	46.18	10.15	5.35	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	100.48	35.85	7.81	4.34	0.25	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	103.73	38.11	9.21	4.78	0.12	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	118.80	31.43	9.71	6.01	0.23	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	77.63	29.44	9.17	4.38	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	93.03	30.86	9.98	2.27	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	122.92	44.62	13.44	6.09	0.00	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	95.40	35.29	8.61	3.87	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	99.27	33.70	6.76	4.72	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	112.18	30.31	9.96	6.20	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	76.85	25.43	6.31	4.59	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	87.76	29.63	5.96	4.56	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	123.08	39.65	9.96	4.89	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	88.91	37.03	7.30	3.58	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	89.46	32.90	7.20	2.82	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	111.52	35.71	7.07	6.30	0.38	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	92.59	35.78	7.90	4.16	0.11	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	105.11	35.88	8.13	3.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	101.68	33.33	8.72	5.13	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	101.56	35.55	8.20	4.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	101.17	32.01	8.09	4.54	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	131.90	42.04	8.46	5.10	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	98.12	31.14	7.55	3.54	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	104.37	39.09	9.72	4.37	0.00	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	142.18	44.66	14.03	6.31	0.00	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	101.19	35.87	9.33	3.32	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	113.92	36.06	8.63	5.31	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	113.63	35.72	8.77	5.64	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	101.48	35.66	9.02	4.71	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	90.77	28.95	8.86	3.58	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	112.59	34.32	10.80	6.17	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	91.30	34.90	7.74	4.30	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	98.62	32.51	8.37	3.57	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	105.07	34.64	11.16	4.43	0.00	0.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	77.21	27.27	5.11	3.92	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	110.52	28.70	6.36	5.47	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	88.49	29.85	4.53	3.20	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	73.56	23.64	7.19	3.59	0.00	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	107.15	28.10	6.19	5.00	0.00	0.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	89.48	27.41	8.67	4.84	0.00	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	77.98	23.83	8.10	3.01	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	86.64	24.11	5.24	2.10	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	75.25	26.59	7.25	3.02	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	95.22	30.11	10.40	4.41	0.24	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	99.56	40.61	9.46	3.78	0.15	0.73
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	116.82	34.07	8.52	3.65	1.22	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	98.56	26.52	9.04	5.12	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	151.32	57.23	14.48	7.92	1.36	3.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	100.65	45.53	14.38	3.89	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	107.33	40.26	10.15	4.96	1.53	5.67
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	145.14	55.92	11.53	5.76	1.07	2.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	88.34	42.67	10.82	2.40	0.00	0.00
Schwann Cells, donor1	11498-119F4	155.72	53.60	14.86	10.16	0.00	0.00
Schwann Cells, donor2	11578-120F3	47.63	17.01	3.40	3.40	0.00	0.00
Schwann Cells, donor3	11659-122F3	129.48	39.87	13.14	8.76	0.00	0.22
Sebocyte, donor1	11220-116B5	95.86	27.94	7.12	8.22	0.00	0.55
Sebocyte, donor2	11301-117B5	59.28	14.71	3.22	2.76	0.00	0.92
Sebocyte, donor3	11378-118B1	73.38	24.53	5.57	3.30	0.00	0.00
Sertoli Cells, donor1	11255-116F4	139.15	46.38	4.97	9.94	3.31	1.66
Sertoli Cells, donor2	11333-117F1	118.62	19.77	8.47	8.47	2.82	0.00
Skeletal Muscle Cells, donor1	11281-116I3	80.32	23.05	8.62	4.40	0.79	0.88
Skeletal Muscle Cells, donor2	11358-117H8	96.86	18.79	9.40	12.29	0.00	0.72
Skeletal Muscle Cells, donor3	11430-118G8	213.19	69.39	24.25	14.21	0.84	0.00
Skeletal Muscle Cells, donor4	11451-119A2	141.23	52.94	7.23	10.68	0.31	0.16
Skeletal Muscle Cells, donor5	11455-119A6	132.00	45.04	10.85	9.36	0.59	0.59
Skeletal Muscle Cells, donor6	11459-119B1	152.67	53.56	9.08	9.70	0.15	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	129.41	36.79	7.94	8.95	0.00	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	125.00	44.09	9.99	5.14	0.29	0.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	162.21	50.99	11.41	11.61	0.20	0.40
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	114.16	40.69	10.78	7.16	0.42	0.25
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	95.54	28.95	14.48	4.34	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	123.56	40.73	11.70	7.98	0.41	0.14
Skin - palm, donor1	10286-104F7	26.86	64.47	21.49	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	63.00	26.38	5.91	5.62	0.14	0.14
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	35.99	13.09	2.45	1.64	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	46.35	24.15	6.49	2.86	0.26	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	80.76	28.77	5.70	7.51	0.42	1.39
Small Airway Epithelial Cells, donor2	11334-117F2	63.30	17.44	3.66	4.22	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	86.48	31.93	4.44	5.71	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	61.38	26.98	3.97	4.35	0.00	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	36.72	12.96	4.63	0.93	0.62	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	265.46	98.49	26.01	15.56	1.56	0.89
Smooth Muscle Cells - Aortic, donor0	11210-116A4	208.68	71.71	15.28	13.52	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	172.82	51.93	13.26	9.28	0.22	0.88
Smooth Muscle Cells - Aortic, donor2	11360-117I1	197.68	77.18	10.24	13.78	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	222.50	59.49	13.91	17.00	0.77	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	66.05	16.01	15.01	2.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	187.51	55.09	10.78	15.04	0.67	0.93
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	141.19	48.54	8.64	10.64	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	220.60	65.17	12.55	16.13	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	93.77	29.63	6.51	8.14	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	109.86	37.21	7.09	6.79	0.00	0.89
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	120.16	35.73	4.56	8.54	0.28	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	156.82	74.99	15.94	11.88	0.00	0.33
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	57.84	15.22	8.52	2.44	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	200.03	56.83	14.40	12.12	0.51	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	257.07	73.45	55.09	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	185.01	52.45	10.49	17.64	0.95	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	106.48	40.41	9.14	7.96	0.00	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	129.57	44.77	10.12	7.32	0.43	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	153.66	58.46	9.34	7.35	0.21	0.31
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	213.61	77.49	13.92	21.35	0.15	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	228.51	66.83	15.09	20.48	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	176.62	64.55	12.25	8.97	0.00	0.60
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	236.59	82.62	16.39	12.29	0.34	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	95.49	32.67	7.54	3.14	0.08	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	104.87	33.92	11.17	7.04	2.11	1.91
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	159.29	43.92	10.47	7.74	1.37	0.46
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	213.75	63.40	18.11	9.06	0.00	2.42
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	165.84	62.26	11.13	13.51	0.00	0.79
Smooth Muscle Cells - Prostate, donor1	11257-116F6	124.77	56.33	10.39	4.66	0.40	0.80
Smooth Muscle Cells - Prostate, donor2	11335-117F3	125.72	44.70	9.02	6.89	0.88	1.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	73.82	26.89	6.09	5.07	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	165.85	70.11	15.98	9.80	0.15	0.60
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	158.29	53.26	15.00	12.75	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	343.73	73.66	40.06	5.17	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	234.86	95.80	11.16	16.74	0.93	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	179.23	62.10	18.18	14.64	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	182.71	52.96	8.46	11.60	0.31	0.94
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	107.97	46.31	13.86	5.60	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	121.38	48.57	13.50	6.75	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	77.08	31.30	7.47	2.34	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	200.33	54.11	10.65	13.82	0.58	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	191.98	59.15	8.41	16.06	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	155.13	44.94	9.59	9.03	0.19	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	120.60	45.42	7.83	7.69	0.00	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	143.61	49.94	9.97	8.63	0.00	0.17
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	161.43	58.57	13.81	5.24	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	176.89	55.05	9.30	12.48	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	139.20	53.47	10.38	10.61	0.66	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	93.04	35.11	8.48	4.97	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	67.83	17.88	5.83	1.75	0.58	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	64.26	20.89	5.55	3.70	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	25.66	5.95	1.12	1.86	2.23	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	85.16	24.43	5.75	6.83	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	75.52	28.67	5.96	4.54	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	89.41	34.66	7.88	6.30	0.39	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	49.27	10.92	4.32	1.78	0.51	0.51
Smooth muscle cells - airway, control, donor2	11967-126D5	56.30	17.97	5.59	1.60	1.20	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	57.27	22.99	4.60	2.51	0.42	0.42
Smooth muscle cells - airway, control, donor4	11969-126D7	57.30	21.08	3.67	2.29	1.38	0.92
Synoviocyte, donor1	11291-117A4	121.53	37.54	10.77	4.88	1.01	0.17
Synoviocyte, donor2	11368-117I9	96.55	27.16	6.87	6.20	0.50	0.67
Synoviocyte, donor3	11440-118H9	72.38	26.81	4.47	5.81	1.12	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	212.25	71.11	16.44	13.22	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	116.94	21.80	11.89	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	143.56	42.14	9.03	8.10	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	85.66	21.58	4.80	4.66	0.14	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	101.28	27.45	6.57	5.41	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	88.19	15.46	4.01	4.58	0.57	0.57
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	92.51	39.98	5.78	8.98	0.49	0.98
Urethra, donor2	10319-105A4	34.17	35.97	21.58	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	115.30	33.21	5.05	7.97	0.27	0.00
Urothelial Cells, donor2	11600-120H7	88.93	15.62	6.41	4.41	0.40	0.00
Urothelial Cells, donor3	11681-122H7	102.68	28.42	5.27	6.42	0.69	0.23
Urothelial cells, donor0	11216-116B1	117.24	32.77	6.46	6.02	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	53.39	17.80	10.68	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	60.04	17.16	8.58	5.72	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	28.07	7.53	8.90	1.37	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	44.08	11.02	7.92	1.38	0.00	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	30.21	11.04	6.97	4.65	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	43.73	18.74	8.33	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	44.05	13.77	9.18	4.59	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	34.69	11.87	3.65	4.56	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	80.06	22.82	5.55	7.77	0.37	0.12
Wilms' tumor cell line:HFWT	10597-108E3	36.08	29.92	14.08	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	50.28	18.71	10.33	3.07	0.00	0.00
achilles tendon, donor2	10292-104G4	47.53	16.53	18.60	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	48.19	10.96	2.55	5.10	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	37.38	11.14	4.64	2.32	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	39.65	10.92	15.19	1.66	0.00	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	78.37	51.70	33.20	6.80	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	77.02	13.21	4.22	9.28	0.28	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	73.60	26.22	11.63	4.86	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	86.56	17.15	7.89	17.15	0.54	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	59.93	17.63	10.58	5.29	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	56.76	11.03	7.76	6.94	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	77.27	19.80	7.38	5.82	0.00	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	100.28	22.82	5.52	13.25	0.00	0.18
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	31.20	11.70	3.90	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	55.54	13.94	8.37	8.37	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	144.47	38.32	9.06	13.20	0.00	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	92.35	18.70	4.68	10.23	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	48.80	8.37	2.79	7.44	0.00	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	49.35	13.57	4.52	3.70	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	85.03	34.69	3.99	6.14	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	72.97	21.34	2.56	7.68	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	80.37	22.75	1.52	8.80	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	87.86	29.13	3.13	7.22	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	45.22	11.36	3.34	6.46	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	92.73	27.68	3.00	5.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	76.19	27.87	5.57	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	115.63	23.35	9.42	13.94	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	54.95	8.72	10.03	4.36	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	46.86	33.74	11.25	5.62	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	102.44	27.55	4.00	5.65	0.00	0.24
adipose tissue, adult, pool1	10010-101C1	68.25	29.78	7.91	4.96	0.31	1.24
adipose, donor1	10184-103D4	53.95	7.04	4.10	0.59	3.52	7.04
adipose, donor2	10185-103D5	40.96	21.90	23.52	2.84	0.00	2.43
adipose, donor3	10186-103D6	50.37	19.88	8.99	2.18	1.09	1.36
adipose, donor4	10187-103D7	74.54	20.80	26.00	3.47	0.00	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	58.55	22.41	13.89	0.79	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	69.12	21.83	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	31.62	6.40	3.47	1.73	0.00	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	135.77	37.52	7.86	4.64	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	78.83	51.01	13.91	4.41	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	98.73	49.02	11.50	4.40	0.34	0.34
amniotic membrane cells, donor3	12237-129G5	50.38	36.24	9.43	2.36	0.00	0.29
amygdala - adult, donor10196	10167-103B5	32.02	11.86	4.74	2.37	0.00	0.00
amygdala, adult, donor10252	10151-102I7	29.81	19.47	8.52	1.01	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	17.43	15.49	9.36	0.97	0.00	0.32
anaplastic carcinoma cell line:8305C	10428-106D5	187.30	65.96	13.24	10.70	1.15	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	295.41	129.95	6.84	17.87	0.22	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	74.16	22.38	15.70	1.00	0.67	0.00
aorta, adult, pool1	10052-101G7	48.64	23.34	8.83	1.96	0.00	0.00
appendix, adult	10189-103D9	60.55	19.79	12.42	3.10	0.00	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	94.93	30.95	2.75	8.25	0.00	0.00
artery, adult	10190-103E1	21.74	20.38	9.51	1.36	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	118.21	43.32	10.58	3.48	0.14	0.14
b cell line:RPMI1788	10427-106D4	79.56	12.79	3.12	2.97	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	130.68	36.35	7.21	8.32	0.28	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	62.52	14.49	3.57	3.18	0.00	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	51.39	26.78	3.35	3.51	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	86.68	10.07	0.00	8.95	0.00	0.00
bladder, adult, pool1	10011-101C2	39.87	24.55	6.74	1.96	0.00	0.22
blood, adult, pool1	10053-101G8	37.65	13.29	2.21	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	91.63	17.98	14.56	0.86	0.00	0.00
bone marrow, adult	10192-103E3	71.53	26.32	8.77	4.72	0.00	0.00
brain, adult, donor1	10084-102B3	43.05	18.45	8.20	4.10	0.00	0.00
brain, adult, pool1	10012-101C3	28.40	16.82	9.13	1.45	0.11	0.11
brain, fetal, pool1	10085-102B4	29.39	13.36	26.71	5.34	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	72.02	23.46	8.92	4.63	0.33	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	60.41	16.23	2.50	3.37	0.00	0.00
breast, adult, donor1	10080-102A8	61.87	32.83	1.26	5.05	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	45.23	16.77	4.07	6.22	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	64.32	20.41	2.47	4.64	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	42.82	19.34	6.68	3.22	1.15	0.23
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	35.59	8.23	1.94	3.15	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	76.17	24.92	13.16	1.41	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	110.15	37.08	6.45	12.25	0.00	0.00
carcinoid cell line:SK-PN-DW	10719-109I8	38.03	26.94	16.80	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	55.36	24.75	10.65	1.06	0.27	0.27
caudate nucleus - adult, donor10196	10177-103C6	10.36	16.12	21.88	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	20.25	17.07	12.55	1.34	0.33	0.17
caudate nucleus, adult, donor10258	10379-105H1	18.34	13.75	14.52	0.76	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	15.38	17.58	20.14	1.10	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	23.31	20.39	11.65	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	27.12	19.22	7.69	1.92	0.00	0.00
cerebellum, adult, pool1	10083-102B2	19.32	16.90	7.59	1.38	0.34	0.34
cerebellum, newborn, donor10223	10357-105E6	15.78	16.61	19.93	0.83	0.00	0.00
cerebral meninges, adult	10188-103D8	30.00	19.16	9.83	1.76	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	16.08	20.46	1.46	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	113.59	30.77	9.78	5.90	0.00	0.29
cervical cancer cell line:ME-180	10553-107I4	105.89	50.54	13.75	4.64	0.17	0.33
cervix, adult, pool1	10013-101C4	53.23	29.29	13.65	2.41	0.10	0.63
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	152.30	58.10	7.38	11.43	0.42	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	71.84	32.66	9.14	5.23	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	124.77	38.53	4.23	12.55	0.62	1.62
choriocarcinoma cell line:SCH	10785-110H2	44.60	25.14	3.08	0.99	0.00	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	52.65	13.52	3.08	4.51	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	107.70	51.29	6.84	9.12	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	160.18	68.81	9.55	8.25	1.59	0.99
chorionic membrane cells, donor3	12240-129G8	118.14	39.01	5.49	7.14	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	63.62	33.32	18.18	3.03	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	136.39	24.97	6.72	16.52	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	97.57	25.76	4.43	9.93	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	55.73	17.72	6.93	2.57	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	62.89	19.11	6.05	0.97	0.24	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	69.84	23.01	10.79	4.07	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	123.08	41.52	16.78	3.83	0.00	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	56.30	13.29	3.13	3.65	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	48.92	14.86	6.63	1.37	0.23	0.23
clear cell carcinoma cell line:TEN	10636-108I6	127.35	61.77	6.77	9.37	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	134.35	51.25	5.86	6.96	0.18	0.37
colon carcinoma cell line:COLO-320	10420-106C6	118.59	39.15	10.64	6.84	0.38	0.00
colon, adult, donor1	10082-102B1	76.16	30.94	4.76	4.76	0.00	0.00
colon, adult, pool1	10014-101C5	106.11	42.18	5.76	8.46	0.35	0.35
colon, fetal, donor1	10070-101I7	51.91	21.63	6.18	3.71	0.62	1.24
common myeloid progenitor CMP, donor1	12130-128D6	110.00	45.84	32.08	9.17	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	108.78	35.69	3.40	25.07	0.00	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	173.12	49.81	4.53	39.24	0.15	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	175.70	54.29	3.10	40.61	0.00	0.14
corpus callosum, adult, pool1	10042-101F6	49.97	36.26	16.03	3.21	0.22	0.44
cruciate ligament, donor2	10295-104G7	38.09	17.83	13.78	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	55.38	32.10	8.83	1.61	0.80	0.00
diencephalon, adult	10193-103E4	24.00	14.88	11.28	2.40	0.24	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	26.63	6.43	4.13	1.38	0.00	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	81.80	28.46	9.23	4.36	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	54.64	20.94	6.74	5.54	0.00	0.48
ductus deferens, adult	10196-103E7	77.74	24.92	7.97	11.96	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	83.53	53.29	5.76	8.64	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	89.01	40.46	7.36	7.36	1.47	0.74
dura mater, adult, donor1	10041-101F5	96.46	42.45	14.87	5.12	0.25	0.50
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	49.08	15.99	9.33	1.78	1.33	1.33
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	75.95	30.95	14.47	4.30	0.00	0.43
embryonic pancreas cell line:1B2C6	10604-108F1	77.69	37.00	12.33	1.23	0.00	0.62
embryonic pancreas cell line:1C3D3	10605-108F2	82.94	29.67	6.96	2.12	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	78.11	26.24	8.34	2.78	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	76.18	26.27	6.57	5.25	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	37.21	9.72	4.02	1.68	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	88.26	28.45	9.79	3.44	0.00	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	96.49	31.20	3.54	5.47	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	52.47	17.23	3.33	2.89	0.11	0.00
epidermoid carcinoma cell line:Ca Ski	10431-106D8	81.39	26.07	6.82	3.85	0.00	0.11
epididymis, adult	10197-103E8	69.28	29.09	9.84	3.77	0.42	0.63
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	45.42	18.27	7.63	1.24	0.00	0.00
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	94.38	29.49	1.57	20.06	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	137.60	40.76	6.42	8.52	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	108.46	32.28	5.02	7.38	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	145.41	41.34	8.18	9.52	0.11	0.00
esophagus, adult, pool1	10015-101C6	47.36	20.81	5.63	3.19	0.00	0.64
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	69.26	44.08	18.66	2.38	0.38	0.00
eye - muscle inferior rectus, donor1	10272-104E2	21.73	28.97	14.49	4.83	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	27.35	25.25	8.42	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	19.35	29.76	10.42	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	24.08	16.05	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	32.06	18.95	30.61	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	46.27	24.66	13.47	1.27	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	79.24	16.28	5.13	4.10	0.00	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	51.76	17.57	4.04	1.66	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	38.47	18.86	10.13	1.22	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	57.65	21.62	3.60	3.60	0.30	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	90.43	29.08	6.22	5.94	0.00	0.18
gall bladder, adult	10198-103E9	87.88	24.38	7.48	6.04	0.97	1.21
gamma delta positive T cells, donor1	11937-126A2	77.31	19.86	18.25	5.37	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	55.65	14.94	9.34	8.96	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	92.94	25.77	5.91	4.86	0.21	0.00
gastric adenocarcinoma cell line:MKN45	10612-108F9	105.61	34.43	5.22	9.09	0.58	0.00
gastric cancer cell line:AZ521	10549-107H9	100.34	32.30	9.67	6.56	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	49.42	21.05	9.15	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	101.89	25.82	2.74	9.60	0.23	0.23
giant cell carcinoma cell line:LU65	10487-107B1	62.19	25.70	7.80	2.87	0.00	0.23
giant cell carcinoma cell line:Lu99B	10433-106E1	70.54	14.70	5.60	4.06	0.28	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	62.85	24.19	5.99	4.74	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	103.23	31.77	9.92	8.13	0.11	0.32
glioblastoma cell line:A172, tech_rep2	10444-106F3	100.83	34.41	9.41	8.01	0.00	0.14
glioblastoma cell line:T98G	10485-107A8	77.26	24.50	7.06	5.41	0.11	0.00
glioma cell line:GI-1	10413-106B8	91.96	14.94	1.46	11.13	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	22.60	14.58	13.12	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	37.10	24.90	10.01	0.73	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	46.55	30.12	15.06	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	29.84	33.04	9.06	1.60	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	97.89	61.18	36.71	19.58	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	76.50	10.93	21.86	43.71	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	20.91	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	100.16	38.08	10.24	2.88	0.32	0.00
hIPS +CCl2, biol_rep1	14383-156B9	49.58	13.31	7.80	3.67	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	50.76	17.38	8.23	2.74	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	59.26	17.39	10.31	2.58	0.64	0.00
hIPS, biol_rep1	14380-156B6	86.24	11.50	20.12	5.75	0.00	0.00
hIPS, biol_rep2	14381-156B7	62.41	17.15	15.09	3.43	0.00	0.69
hIPS, biol_rep3	14382-156B8	18.76	16.55	9.93	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	62.35	17.53	4.02	6.61	0.00	0.00
heart - mitral valve, adult	10205-103F7	41.86	23.92	8.97	2.09	0.00	0.30
heart - pulmonic valve, adult	10206-103F8	27.72	18.30	9.15	1.57	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	67.44	54.12	5.83	5.00	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	58.97	20.00	5.31	2.45	0.00	0.20
heart, adult, diseased, donor1	10051-101G6	54.08	23.85	10.22	1.28	0.43	0.00
heart, adult, pool1	10016-101C7	43.47	26.45	7.36	2.53	0.00	0.00
heart, fetal, pool1	10046-101G1	52.06	29.57	9.96	3.18	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	158.89	56.46	9.26	7.10	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	68.97	45.19	3.57	3.57	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	161.32	82.65	8.73	16.46	0.11	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	174.17	87.27	7.65	17.24	0.00	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	157.54	76.30	6.77	16.37	0.30	0.00
hepatoma cell line:Li-7	10484-107A7	101.76	30.25	7.34	4.34	0.22	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	53.67	7.74	2.81	2.91	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	16.09	11.36	7.57	0.95	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	28.37	22.45	7.96	0.82	0.00	0.20
hippocampus, adult, donor10258	10374-105G5	29.38	11.95	4.98	1.49	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	16.57	20.44	11.98	2.82	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	78.73	18.92	5.49	5.49	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	82.67	21.21	7.07	3.34	0.59	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	67.79	16.25	7.87	4.32	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	49.62	20.30	6.77	2.26	0.00	3.38
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	55.00	16.01	7.23	1.03	1.03	2.84
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	69.85	20.50	10.63	2.28	0.76	2.28
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	32.70	16.06	11.68	1.17	1.46	3.50
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	42.44	21.54	18.10	1.94	0.86	2.15
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	43.79	21.69	12.93	1.67	0.42	3.75
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	60.38	19.65	12.55	3.55	0.24	1.89
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	58.34	23.30	14.46	3.38	0.48	1.61
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	58.58	24.24	8.75	2.02	0.00	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	75.58	18.00	7.51	3.91	0.94	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	68.78	17.20	5.90	3.44	0.49	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	43.64	14.84	6.98	2.62	1.75	1.75
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	71.78	24.05	8.02	3.63	0.57	1.91
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	77.18	23.11	10.90	0.87	0.44	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	45.48	12.49	8.50	2.00	1.50	5.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.92	22.04	17.14	2.07	1.51	4.14
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	43.65	22.74	20.01	0.91	1.36	3.64
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	27.56	20.99	25.06	0.94	0.63	3.13
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	51.11	22.54	15.19	4.57	0.33	2.12
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	60.67	20.03	16.55	6.10	1.45	1.74
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	48.43	17.34	19.73	2.39	0.90	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	84.24	22.17	7.02	4.80	0.18	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	93.86	21.97	9.13	6.28	0.29	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	82.07	17.56	8.17	3.67	0.41	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	80.98	25.70	10.21	4.93	2.82	4.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	84.25	29.14	6.65	2.22	1.58	3.17
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	86.85	22.70	11.20	5.14	2.72	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	41.37	23.27	17.58	1.03	1.03	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	41.18	23.25	15.28	1.99	0.66	1.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	43.61	21.29	15.65	2.82	0.00	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	69.79	21.99	14.57	6.14	1.28	2.05
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	63.61	35.59	16.66	1.51	1.51	3.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	57.80	20.50	14.45	5.71	1.34	4.70
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	92.26	20.29	6.04	4.11	0.72	0.24
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	67.29	11.59	5.35	4.90	0.45	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	79.03	15.12	7.32	3.90	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	71.82	22.92	10.09	0.92	0.92	3.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	9.76	13.01	0.00	6.51	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	60.89	17.54	7.61	0.33	1.65	6.29
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	40.50	15.87	10.95	1.64	0.55	2.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	41.25	23.16	12.30	1.09	0.36	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	32.38	13.52	11.39	0.36	0.71	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	41.77	10.74	11.93	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	62.57	21.67	14.22	3.52	0.95	2.03
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	39.60	16.43	10.51	2.96	1.08	1.35
immature langerhans cells, donor1	11904-125F5	47.70	12.35	7.51	7.51	0.24	0.24
immature langerhans cells, donor2	11905-125F6	39.61	9.51	8.71	7.13	0.00	0.00
insula, adult, pool1	10039-101F3	43.25	20.63	11.73	2.65	0.00	0.09
keratoacanthoma cell line:HKA-1	10791-110H8	116.73	25.04	6.50	6.83	0.00	0.00
kidney, adult, pool1	10017-101C8	73.99	26.53	6.51	6.71	0.20	0.40
kidney, fetal, pool1	10045-101F9	86.65	36.22	11.39	4.74	0.07	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	135.20	42.75	9.94	6.67	0.28	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	96.63	27.79	3.59	7.05	0.14	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	51.93	44.41	6.42	2.94	0.00	0.00
left atrium, adult, donor1	10079-102A7	44.13	17.98	3.81	2.18	0.54	0.54
left ventricle, adult, donor1	10078-102A6	34.89	23.26	8.60	1.52	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	91.11	27.36	6.84	4.10	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	119.27	48.14	16.17	14.37	1.80	0.72
leiomyoma cell line:15242A	10570-108B3	148.91	57.61	10.87	9.78	1.09	1.63
leiomyoma cell line:15425	10571-108B4	117.77	52.21	13.11	6.56	0.97	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	158.73	38.10	0.00	12.70	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	107.69	39.73	5.23	8.36	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	162.45	25.97	5.43	9.56	0.24	0.24
liposarcoma cell line:KMLS-1	10782-110G8	111.53	40.93	7.19	8.75	0.16	0.31
liposarcoma cell line:SW 872	10726-110A6	114.16	36.92	10.97	5.48	0.12	0.12
liver, adult, pool1	10018-101C9	249.25	70.01	5.19	36.14	0.65	4.54
liver, fetal, pool1	10086-102B5	106.30	47.04	1.88	8.47	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	18.08	9.48	5.25	0.58	0.00	0.00
locus coeruleus, adult, donor10252	10165-103B3	29.34	19.38	7.75	0.92	0.00	0.00
locus coeruleus, adult, donor10258	10375-105G6	25.96	17.49	11.29	1.69	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	11.78	12.62	4.21	1.68	0.42	0.84
lung adenocarcinoma cell line:A549	10499-107C4	68.78	16.47	2.77	9.69	0.00	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	70.32	22.06	7.58	2.76	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	42.58	19.90	4.61	2.77	0.13	0.00
lung, adult, pool1	10019-101D1	63.20	24.69	6.38	3.43	0.12	0.47
lung, fetal, donor1	10068-101I5	51.09	23.69	12.56	1.71	0.29	0.00
lung, right lower lobe, adult, donor1	10075-102A3	47.65	20.62	10.08	3.21	0.00	0.46
lymph node, adult, donor1	10077-102A5	58.70	14.20	5.68	2.84	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	140.05	19.51	3.51	10.96	0.22	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	44.83	8.45	3.62	3.02	0.00	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	56.92	37.38	7.65	4.25	0.00	0.00
mature adipocyte, donor1	12231-129F8	138.97	62.60	3.55	7.55	0.00	0.00
mature adipocyte, donor2	12232-129F9	121.20	65.37	4.77	9.75	0.21	0.21
mature adipocyte, donor3	12233-129G1	137.97	58.79	5.22	8.06	0.00	0.24
mature adipocyte, donor4	12234-129G2	114.76	47.91	2.37	7.63	0.26	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	100.31	31.69	7.62	7.86	0.48	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	3.38	6.77	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	27.77	19.31	6.62	1.66	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	23.83	12.71	6.99	0.64	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	15.78	8.53	3.41	0.43	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	24.64	11.14	6.75	0.68	0.00	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	28.65	20.37	4.88	1.70	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	21.19	11.56	1.93	1.93	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	0.00	0.00	0.00	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	26.92	14.00	7.54	1.08	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	29.20	12.33	5.84	1.30	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	32.20	15.94	6.97	0.93	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	40.57	22.86	11.92	1.88	0.08	0.16
medulla oblongata, newborn, donor10223	10361-105F1	27.08	23.96	10.42	2.08	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	44.95	14.39	5.76	2.44	0.44	0.00
medulloblastoma cell line:ONS-76	10759-110E3	61.26	23.60	8.68	3.30	0.00	0.00
melanoma cell line:COLO 679	10514-107E1	75.32	25.59	5.61	5.89	0.43	1.15
melanoma cell line:G-361	10465-106H6	104.51	27.96	6.79	9.23	0.54	2.17
meningioma cell line:HKBMM	10691-109F7	84.30	31.66	6.69	5.25	0.54	0.00
merkel cell carcinoma cell line:MKL-1	10843-111E6	54.63	24.67	22.03	0.88	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	53.92	24.11	12.44	2.07	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	197.93	73.34	11.35	13.04	0.31	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	117.98	31.99	4.91	9.45	0.18	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	128.79	43.48	6.63	7.45	0.00	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	103.67	28.38	3.93	6.18	0.28	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	125.75	33.31	5.20	6.74	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	120.77	38.17	9.02	3.47	0.69	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	138.34	23.86	2.92	14.25	0.17	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	109.26	34.27	6.21	6.10	0.12	0.35
mesenchymal precursor cell - cardiac, donor3	11754-123G8	144.44	46.29	11.14	10.61	0.40	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	143.55	44.43	8.51	10.40	0.54	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	132.73	41.54	6.40	10.10	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	129.11	26.02	3.95	16.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	150.96	50.78	8.30	7.75	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	145.92	47.13	10.47	8.03	0.35	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	120.05	39.00	7.76	8.17	0.20	0.61
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	106.76	33.79	6.47	11.50	0.72	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	97.35	26.79	3.83	7.34	0.00	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	84.13	29.18	5.93	8.21	0.91	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	93.98	38.18	7.97	4.20	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	122.69	44.38	6.58	7.32	0.30	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	121.49	30.02	3.24	7.44	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	94.25	27.24	7.00	6.26	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	101.59	32.62	6.87	7.44	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	131.36	41.68	12.21	9.26	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	92.70	39.27	7.31	10.50	0.91	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	77.25	34.79	7.16	6.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	110.46	47.64	8.11	7.33	0.26	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	95.51	39.74	12.02	5.55	0.00	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	77.67	34.36	7.77	7.06	0.24	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	94.43	34.18	8.80	7.45	0.00	0.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	89.60	35.76	9.04	7.47	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	76.92	38.46	7.41	5.56	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	48.30	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	99.22	40.09	14.71	5.77	0.29	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	99.28	41.05	12.72	8.25	0.00	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	105.03	39.66	11.06	5.05	0.72	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	97.53	44.73	11.00	8.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	87.27	35.24	7.05	4.70	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	85.56	36.84	7.78	5.32	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	74.74	43.81	15.46	6.01	0.00	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	117.58	38.28	10.94	8.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	77.47	30.99	10.33	10.33	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	104.91	44.50	12.02	7.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	100.39	36.37	4.36	4.36	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	116.74	44.78	13.86	3.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	108.76	35.98	9.00	2.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	97.57	43.54	11.27	6.61	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	75.55	35.68	4.20	2.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	94.38	30.80	11.92	2.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	71.51	38.14	4.77	9.53	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	98.43	30.24	8.89	5.34	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	104.79	36.55	15.84	4.87	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	27.05	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	101.34	32.30	12.03	6.97	0.63	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	86.23	21.73	4.83	8.28	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	85.97	32.24	2.15	2.15	2.15	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	119.75	27.94	3.99	7.98	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	72.32	37.88	10.33	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	78.23	24.86	5.70	2.44	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	76.27	24.63	7.15	0.79	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	71.92	20.63	4.13	2.95	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	63.90	27.12	5.92	2.81	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	73.52	21.39	8.02	1.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	85.15	44.94	4.73	4.73	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	105.29	25.68	7.70	5.14	0.00	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	99.13	35.80	4.13	6.88	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	156.36	115.29	2.47	9.40	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	116.64	102.06	0.00	6.73	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	152.66	106.22	1.91	10.81	0.00	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	197.46	185.78	6.45	11.69	0.81	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	274.75	176.63	2.18	15.26	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	193.86	187.52	5.07	10.14	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	169.93	83.75	3.03	22.45	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	185.28	122.01	9.04	13.56	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	186.98	102.96	3.29	15.65	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	87.11	45.64	5.95	5.36	0.20	0.20
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	96.05	57.11	4.54	6.49	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	115.10	56.02	6.11	4.07	0.00	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	85.11	58.03	9.28	3.87	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	92.84	61.66	15.36	1.65	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	71.82	37.30	4.87	4.87	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	115.39	47.01	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	75.83	26.72	3.08	3.49	0.10	0.21
mesothelioma cell line:Mero-25	10850-111F4	104.40	32.00	10.67	5.67	0.23	0.45
mesothelioma cell line:Mero-41	10851-111F5	114.90	47.43	13.20	11.25	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	98.32	29.89	7.75	4.21	0.00	0.44
mesothelioma cell line:Mero-82	10853-111F7	80.42	26.81	2.63	3.15	0.79	0.26
mesothelioma cell line:Mero-83	10854-111F8	99.07	32.17	6.13	5.62	0.34	0.68
mesothelioma cell line:Mero-84	10855-111F9	83.92	45.75	13.65	5.81	0.25	0.25
mesothelioma cell line:Mero-95	10856-111G1	120.71	28.16	2.90	8.70	0.83	0.21
mesothelioma cell line:NCI-H2052	10847-111F1	96.74	36.61	8.61	8.12	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	74.93	20.81	3.98	6.70	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	97.20	36.73	8.03	8.20	0.34	0.34
mesothelioma cell line:NCI-H28	10845-111E8	73.29	17.81	10.94	4.58	0.51	0.25
mesothelioma cell line:No36	10857-111G2	54.80	20.88	3.26	2.61	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	170.70	47.42	10.30	10.84	0.81	0.00
migratory langerhans cells, donor1	11901-125F2	26.10	4.99	1.54	2.30	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	47.99	11.60	4.03	3.30	0.12	0.24
migratory langerhans cells, donor3	11903-125F4	36.26	8.44	3.23	1.26	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	87.82	44.07	9.14	0.98	0.33	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	80.96	21.83	6.78	1.70	0.00	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	98.13	27.41	4.84	5.99	0.00	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	133.01	40.15	4.76	13.32	0.19	0.38
myelodysplastic syndrome cell line:SKM-1	10772-110F7	131.57	24.02	2.96	9.61	0.55	0.00
myeloma cell line:PCM6	10474-106I6	89.54	17.39	3.76	5.34	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	66.45	29.93	8.62	2.03	0.00	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	76.49	22.56	5.49	7.65	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	79.67	30.75	7.02	2.67	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	67.66	23.02	6.47	3.31	0.07	0.00
nasal epithelial cells, donor2	12227-129F4	89.97	13.80	9.94	4.42	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	82.36	18.63	12.19	3.91	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	91.86	13.66	5.99	3.74	0.00	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	98.06	51.04	16.03	5.06	0.21	0.63
neuroblastoma cell line:NH-12	10555-107I6	119.45	29.07	16.21	4.47	0.19	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.16	12.81	9.01	1.19	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	56.07	27.24	12.20	1.58	0.00	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	49.91	12.08	5.84	1.61	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	39.42	40.05	55.95	1.27	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	132.82	54.83	10.91	6.92	0.00	0.00
neutrophil PMN, donor1	12133-128D9	119.00	133.87	29.75	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	53.12	13.28	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	47.35	18.94	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	61.90	18.94	7.44	5.07	0.51	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	57.64	10.41	7.20	4.00	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	132.73	42.32	15.71	5.77	0.64	0.32
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	137.95	46.51	10.77	5.78	0.00	0.26
nucleus accumbens, adult, pool1	10037-101F1	36.65	21.37	14.44	2.25	0.00	0.00
occipital cortex - adult, donor10196	10172-103C1	20.60	8.24	10.30	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	30.06	19.86	5.37	1.07	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	27.66	20.74	8.73	1.09	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	37.79	16.27	11.55	1.84	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	37.33	11.16	13.30	0.43	0.00	0.00
occipital pole, adult, pool1	10036-101E9	39.74	19.87	8.75	2.84	0.00	0.00
olfactory region, adult	10195-103E6	25.79	14.33	7.07	1.53	0.00	0.19
optic nerve, donor1	10277-104E7	28.01	24.01	10.01	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	233.06	42.60	6.38	24.72	0.91	0.57
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	121.04	70.07	17.45	3.85	0.00	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	61.46	12.87	3.56	3.89	0.00	0.00
oral squamous cell carcinoma cell line:SAS	10544-107H4	75.66	19.87	6.01	3.93	0.00	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	136.99	47.03	7.35	8.23	0.29	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	54.19	19.62	1.87	4.67	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	81.85	19.51	1.91	9.75	0.42	0.64
ovary, adult, pool1	10020-101D2	52.67	36.86	9.96	2.53	0.44	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	83.96	35.93	6.78	4.03	0.00	0.00
pancreas, adult, donor1	10049-101G4	153.32	29.16	8.47	21.63	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	66.25	28.79	2.24	3.63	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	106.64	27.26	7.84	6.30	0.51	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	71.20	27.16	5.13	3.97	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	43.11	21.78	10.43	2.29	0.00	0.18
parietal cortex, adult, donor10258	10373-105G4	30.83	10.28	20.55	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	22.57	6.58	11.29	0.94	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	23.09	15.39	7.13	1.14	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	42.83	20.97	7.93	2.11	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	27.16	19.40	19.40	0.97	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	21.31	12.34	10.47	1.12	0.37	0.00
parotid gland, adult	10199-103F1	202.88	73.38	6.78	38.85	0.00	0.00
penis, adult	10200-103F2	37.06	22.56	4.30	2.69	0.54	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	29.75	29.94	21.94	0.37	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	100.53	26.66	6.41	8.01	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	27.09	17.42	9.68	1.94	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	41.45	6.51	4.74	2.37	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	26.96	8.15	5.64	1.25	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	81.96	34.40	17.20	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	100.07	42.22	14.59	10.94	0.00	1.04
pituitary gland, adult, donor10258	10378-105G9	52.78	28.09	9.36	6.81	0.00	0.85
placenta, adult, pool1	10021-101D3	109.44	48.27	9.14	8.28	0.22	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	78.26	21.98	7.15	5.43	0.13	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	62.72	28.33	5.91	3.89	0.16	0.16
pons, adult, pool1	10033-101E6	29.00	14.72	6.11	1.72	0.00	0.26
postcentral gyrus, adult, pool1	10032-101E5	41.67	20.31	12.12	2.35	0.00	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	338.81	133.85	25.10	29.28	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	137.70	27.54	16.52	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	117.36	70.41	0.00	23.47	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	98.32	28.99	4.81	5.10	0.44	0.15
prostate cancer cell line:PC-3	10439-106E7	70.79	19.42	4.36	3.45	0.18	0.36
prostate, adult, pool1	10022-101D4	44.53	26.94	8.25	2.27	0.09	0.27
putamen, adult, donor10196	10176-103C5	15.34	15.11	20.77	0.00	0.00	0.00
putamen, adult, donor10252	10152-102I8	19.61	17.65	19.61	3.92	0.00	1.96
putamen, adult, donor10258, tech_rep1	10372-105G3	36.06	16.39	31.69	1.09	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	17.64	15.95	16.43	0.00	0.24	0.24
putamen, newborn, donor10223	10365-105F5	9.00	3.00	5.25	2.25	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	43.64	22.98	4.36	4.36	0.00	0.00
rectum, fetal, donor1	10067-101I4	98.76	33.38	13.91	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	88.19	25.23	8.69	6.78	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	84.08	29.41	5.38	4.14	0.00	0.00
retina, adult, pool1	10030-101E3	50.00	27.33	15.01	1.69	0.00	0.30
retinoblastoma cell line:Y79	10475-106I7	56.12	17.67	6.75	1.30	0.00	0.26
rhabdomyosarcoma cell line:KYM-1	10787-110H4	71.80	44.26	10.94	3.44	0.00	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	38.81	16.87	3.94	1.97	0.00	0.00
sacrococcigeal teratoma cell line:HTST	10695-109G2	100.04	40.17	6.06	0.76	0.00	0.00
salivary acinar cells, donor1	11771-123I7	50.50	9.39	3.40	3.72	0.16	0.16
salivary acinar cells, donor2	11772-123I8	40.62	13.91	3.72	1.93	0.00	0.14
salivary acinar cells, donor3	11773-123I9	31.78	11.92	1.99	0.66	0.00	0.00
salivary gland, adult, pool1	10093-102C3	148.14	49.76	6.29	17.73	0.57	1.14
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	89.96	19.31	6.66	4.64	0.08	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	84.64	18.81	5.29	4.35	0.24	0.00
seminal vesicle, adult	10201-103F3	84.12	25.40	10.58	7.41	1.06	1.06
serous adenocarcinoma cell line:JHOS-2	10639-108I9	94.50	32.31	9.72	7.53	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	79.01	34.22	9.31	4.78	0.25	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	111.39	32.11	13.05	6.02	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	77.23	51.18	3.63	6.85	0.27	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	91.19	23.76	6.41	4.86	0.00	0.55
signet ring carcinoma cell line:NUGC-4	10483-107A6	142.83	59.74	12.64	10.84	0.39	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	17.02	9.93	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	29.98	24.71	6.36	1.20	0.00	0.00
skeletal muscle, fetal, donor1	10066-101I3	39.20	21.11	12.06	2.01	0.00	0.00
skin, adult, donor1	10074-102A2	67.85	33.93	20.36	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	82.69	32.19	11.36	1.89	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	109.73	56.37	15.68	5.34	0.33	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	36.88	12.61	6.93	2.21	0.32	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	59.56	20.43	5.20	1.35	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	59.67	11.87	7.42	3.13	0.00	0.00
small cell lung carcinoma cell line:NCI-H82	10842-111E5	90.40	20.43	5.47	2.57	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	163.44	52.74	10.02	13.29	0.22	0.00
small intestine, adult, pool1	10024-101D6	192.66	83.85	7.17	14.93	2.15	1.91
small intestine, fetal, donor1	10064-101I1	98.77	51.84	11.30	9.34	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	227.22	69.24	11.80	29.24	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	28.43	20.68	7.24	0.78	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	181.18	26.00	6.16	21.44	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	24.55	15.14	8.95	0.69	0.00	0.00
spinal cord, adult, donor10252	10159-103A6	26.02	13.41	3.94	0.39	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	13.84	4.15	2.77	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	55.50	30.49	19.51	2.44	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	22.04	10.10	4.13	1.38	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	141.74	50.93	11.20	6.87	0.15	0.15
spleen, adult, pool1	10025-101D7	45.93	13.11	4.41	2.42	0.11	0.11
spleen, fetal, pool1	10044-101F8	62.61	20.18	6.52	4.85	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	34.99	6.94	2.38	1.55	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	67.60	32.09	9.68	3.23	0.00	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	65.70	18.87	4.19	2.80	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	114.93	32.45	9.38	4.69	0.39	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	107.49	29.83	10.81	8.22	0.00	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	32.62	21.60	5.93	1.27	0.00	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	88.42	28.77	5.08	6.77	0.00	0.00
stomach, fetal, donor1	10062-101H8	113.21	45.92	16.02	4.27	0.00	0.00
submaxillary gland, adult	10202-103F4	132.17	39.31	7.41	14.81	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	34.27	22.02	4.36	1.04	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	18.62	11.38	9.31	1.55	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	20.49	24.02	4.24	1.41	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	70.16	24.30	8.25	4.36	0.00	0.00
temporal lobe, adult, pool1	10031-101E4	52.81	24.50	12.29	2.54	0.08	0.00
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	34.19	14.96	12.82	2.14	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.01	9.23	13.19	0.88	0.00	0.00
tenocyte, donor1	11763-123H8	175.60	64.23	9.77	11.52	0.35	0.35
tenocyte, donor2	11765-123I1	122.84	47.31	8.39	9.54	0.76	0.38
tenocyte, donor3	11768-123I4	134.92	52.26	8.15	11.12	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	80.73	20.74	5.10	4.59	0.00	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	95.57	18.19	2.77	3.08	0.31	0.31
teratocarcinoma cell line:PA-1	10807-111A6	80.43	19.06	4.34	3.72	0.31	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	88.48	30.85	4.06	7.49	0.13	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	45.76	21.18	7.56	0.76	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	40.79	10.91	2.07	1.74	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	67.75	22.80	3.91	6.51	0.33	0.33
testis, adult, pool1	10026-101D8	76.77	35.86	12.03	5.91	0.54	2.90
testis, adult, pool2	10096-102C6	98.34	44.21	21.65	4.96	0.45	0.00
thalamus - adult, donor10196	10168-103B6	23.18	7.73	14.35	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	29.54	19.85	9.38	1.09	0.00	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	32.33	18.48	24.63	3.08	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	18.12	16.80	10.05	1.32	0.00	0.16
thalamus, newborn, donor10223	10366-105F6	9.78	7.48	7.48	1.73	0.00	0.00
throat, adult	10209-103G2	52.18	14.48	8.24	2.75	0.50	0.25
throat, fetal, donor1	10061-101H7	45.71	28.34	11.27	2.13	0.00	0.61
thymic carcinoma cell line:Ty-82	10803-111A2	74.52	29.41	13.12	3.38	0.00	0.20
thymus, adult, pool1	10027-101D9	45.33	19.78	22.27	1.59	0.30	0.89
thymus, fetal, pool1	10043-101F7	52.47	18.91	13.82	2.91	0.00	0.00
thyroid carcinoma cell line:KHM-5M	10776-110G2	74.86	15.96	3.46	10.37	0.13	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	95.27	22.63	7.68	6.15	0.00	0.14
thyroid, adult, pool1	10028-101E1	97.61	42.92	9.24	6.81	0.47	0.37
thyroid, fetal, donor1	10060-101H6	65.65	39.55	16.08	3.69	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	67.75	24.64	43.11	0.00	0.00	0.00
tongue, adult	10203-103F5	45.59	15.82	8.14	2.33	0.23	0.23
tongue, fetal, donor1	10059-101H5	53.60	26.80	10.64	3.15	0.00	0.00
tonsil, adult, pool1	10047-101G2	72.83	22.04	10.62	4.51	0.20	0.00
trachea, adult, pool1	10029-101E2	79.92	26.83	5.89	5.89	0.41	0.33
trachea, fetal, donor1	10058-101H4	88.86	44.62	15.00	3.46	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	149.15	52.08	14.53	5.67	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	93.41	24.11	6.08	10.13	0.00	0.00
transitional-cell carcinoma cell line:JMSU1	10492-107B6	80.22	13.01	4.39	5.48	0.78	0.94
tridermal teratoma cell line:HGRT	10694-109G1	146.49	64.69	11.42	5.71	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	88.46	20.74	4.06	6.09	0.08	0.00
umbilical cord, fetal, donor1	10057-101H3	75.11	27.12	6.26	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	56.48	29.86	12.63	3.24	0.00	0.00
uterus, fetal, donor1	10055-101H1	68.60	31.23	15.36	4.61	0.00	0.00
vagina, adult	10204-103F6	34.89	32.31	2.58	0.65	0.00	0.00
vein, adult	10191-103E2	40.55	21.70	8.11	2.63	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	35.52	4.01	1.87	0.80	0.00	0.00